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This thesis describes investigations designed to study 
the potential role of collagenolytic enzymes involved in the 
healing of intestinal wounds and the growth and spreading 
of colorectal tumor cells. Although the healing of wounds 
and invasion and metastasis of tumor cells do not seem to 
have a lot in common, a detailed analysis of the cellular 
and molecular events that take place does reveal remarkable 
similarities [1,2,3]. The loss of regulation of cellular 
behaviour during carcinogenesis is basically controlled by 
the same peptide mediators that play an important role in 
tissue repair and wound healing [4,5] . These peptides 
(cytokines) have a critical role in the control of collagen 
degradation, the recruitment and formation of new 
fibroblasts, the formation of new collagen and other 
molecules of the extracellular matrix and the formation of 
new blood vessels, processes common to both carcinogenesis 
and tissue repair. 
Both wound healing and carcinogenesis also feature the 
coordinated activity of proteolytic enzymes and their 
natural inhibitors. The consequences of their combined 
action on extracellular matrices determines to a large 
extent the outcome of the physiological or pathological 
process. 
Both issues are briefly introduced below with the 
emphasis on the possible role that proteolytic enzymes of 
the metalloproteinase class might play. Also, the biology 
of the extracellular matrix component collagen is briefly 
reviewed as an understanding of this protein is vital to the 
work presented. 
WOUND HEALING 
The proper healing of wounds, after the inevitable damage 
of connective tissues, is a complex sequence of biological 
activities which requires the mobilization of a number of 
different cell types at appropriate time intervals. For 
simplification wound healing has been divided into three 
distinct, but overlapping phases : inflammation, granulation 
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tissue formation and matrix formation and remodelling 
(Figure 1). 
В 







Ficrure 1; Phases of wound repair. Healing of a wound has been 
arbitrarily divided into three phases: (A) inflammation (early and 
late), (B) granulation tissue formation, and (C) matrix formation 
and remodelling. Those phases overlap considerably with one 
another and are plotted along the abscissa as a logarithmic 
function of time. Inflammation is divided into early and late 
phases denoting neutrophil-rich and mononuclear cell-rich 
infiltrates, respectively. The magnitude of wound contraction 
parallels granulation tissue formation, as indicated. Collagen 
accumulation actually begins shortly after the onset of 
granulation tissue formation, continuing throughout the phase of 
matrix formation and remodelling. From: Clark R.A.F. Overview and 
general considerations of wound repair. Chapter 1 pp 3-34. In: 
The Molecular and Cellular Biology of Wound Repair. Clark R.A.F. 
and Henson P.M.(eds). Plenum Publishing Coop. New York, 19ΘΘ. 
(with permission). 
Following injury, blood vessel disruption leads to 
extravasation of blood constituents, with concomitant 
platelet aggregation and blood coagulation. Coagulation 
factors such as collagen and laminin induce the formation 
of a gel that seals off the exposed area from the 
environment. This temporary gel consists of fibrin, 
fibronectin, platelets and entrapped blood cells. Mediators 
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released by blood coagulation, complement pathways and cell 
activation or death at the wound site induce the influx of 
inflammatory leucocytes. They also increase the permeability 
of undamaged vessels adjacent to the wound resulting in more 
widespread leakage of plasma proteins. The influx of 
neutrophils attempts to clear the wound area of foreign 
particles, especially bacteria, but will cease after the 
first few days of tissue injury if no wound infection has 
occurred. However, if contamination has not been cleared 
effectively the generation of granulocyte chemoattractants 
will persist and interfere with the next phases of wound 
healing. 
The influx of monocytes and their conversion to 
macrophages occurs slightly later and marks the beginning 
of tissue repair. Macrophages phagocytose and digest 
pathogenic organisms, scavenge tissue debris, including 
degenerated neutrophils and release a number of biologically 
active substances such as vasoactive mediators, growth 
factors and enzymes. Many of these substances facilitate the 
recruitment of additional inflammatory cells and assist the 
macrophage in tissue decontamination and debridement. The 
inflammatory reaction continues with increasing numbers of 
macrophages accumulating and fibroblasts moving into the 
gel. The fibroblasts are responsible for the deposition of 
loose connective tissue and the onset of angiogenesis. This 
newly formed tissue has a distinct granular appearance and 
is therefore referred to as granulation tissue. The origin 
of wound fibroblasts and the signals that induce their 
proliferation and migration into a wound space are as yet 
unknown. Fibroblasts migrating into a wound area initially 
deposit great quantities of fibronectin. Fibronectins are 
cell-adhesive and matrix-organizing (glyco)-proteins that 
aid wound healing by stimulating cell attachment and 
migration and probably function as a template for collagen 
deposition. 
The final phase of wound repair which can continue for 
many years is the elimination of fibronectin from the matrix 
and the accumulation of type I collagen fibres that provide 
the remaining scar with increasing tensile strength. 
The elimination of connective tissue debris during the 
healing process is a fundamental prerequisite in order to 
13 
restore normal function. It has been shown that connective 
tissue degrading enzymes [6,7,8], secreted by infiltrating 
granulocytes and macrophages and by local mesenchymal cells 
involved in the healing process, are the means by which the 
organism achieves this important task. 
INTESTINAL WOUND HEALING 
Much of our current knowledge on wound healing has been 
obtained from studies on skin wounds. Although it seems 
likely that all wounds heal by common mechanisms, a somewhat 
different physiological environment may cause tissue-
specific alterations in the repair process. It has been 
shown that significant metabolic differences exist between 
healing in the gastrointestinal tract and skin [9]. Also, 
collagen production by fibroblasts from colon and skin 
appears to be affected differently by various regulatory 
compounds [10]. Thus, one should exert caution in 
extrapolating the results from research on skin repair to 
the healing of other soft tissues [11] . 
The complexity of intra-abdominal healing and the fact that 
complications that might occur during the healing of a bowel 
wound are very difficult to diagnose in early stages of 
healing frequently leads to a prolonged morbidity or even 
mortality [12]. A multitude of factors such as old age, 
local infections, the nutritional condition of the patient, 
oxygen supply to the anastomoses, suture techniques and the 
location of the anastomosis have been linked to impaired 
anastomotic healing [13,14]. 
A dominating factor in the outcome of large bowel surgery 
is the occurrence and extent of anastomotic leakage. In 
order to be able to tackle the problems brought about by 
anastomotic leakage it is necessary to define the parameters 
that control the onset and progress of this complication. 
From previous studies, both clinical and experimental, is 
has become clear that disturbed intestinal healing is mainly 
confined to the large bowel [15,16]. Structural and 
functional differences between the small and large bowel 
therefore might hold the clue to improve large bowel 
surgery. 
It has been known for some time from a number of 
14 
experimental studies including both small and large bowel 
that the submucosa, a thin layer of connective tissue, is 
crucial to proper healing [17] . 
Figure 2 : A scanning electron micrograph showing the collagenous 
framework of the submucosa of the rat small intestine. Collagen 
fibres are arranged in two sets of helices that interweave. 
Angles formed by two helices are slightly different, depending 
on the area of the wall. The everted mucosa with villi is seen 
in the top left hand corner. From: Komura T. The lattice 
arrangement of the rat small intestine: scanning electron 
microscopy. Cell Tissue Res 251: 117-121, 1988. 
The submucosa, a connective tissue sheet interspersed 
between the epithelial layer lining the lumen and the 
muscular layers surrounding the gut, is composed almost 
entirely of collagen fibrils (Figure 2, ref.18). It was 
shown that, in order to construct a proper intestinal 
anastomosis, sutures have to be anchored in this layer. 
Based on this observation much of the scientific attention 
became focused on the collagen metabolism in the anastomosis 
and its implications for uncompromised healing. Collagen 
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levels in healing wounds have been quantified by measuring 
hydroxyproline, an amino acid residue unique to collagens. 
From these studies the hypothesis was generated that during 
the first post-operative days the restoration of the so 
called "collagenous equilibrium" is vital for the bowel to 
regain its original strength [19]. 
Investigations in animal models have shown that during 
the first day after operation the anastomotic collagen 
concentration is massively and transiently reduced [for 
review, see 11] . It has been inferred that (localized) 
collagen degradation occurs in the anastomotic area in the 
early post-operative period. Indeed, a certain amount of 
resorption of the extracellular matrix appears to be an 
integral part of tissue repair in general [20] . 
Subsequently, de novo collagen synthesis overtakes 
degradation and restores the collagen content to - or above 
- pre-operative levels. It has been shown recently in our 
laboratory that anastomotic collagen synthesis may be 
significantly increased already within one day after 
operation [21]. A delayed or only partial recovery of pre-
operative collagen levels or a prolonged state of collagen 
degradation is then hypothesized as the possible cause of 
loss of anastomotic strength, thereby increasing chances for 
anastomotic leakage. Although it was recognised in an early 
stage that excessive collagen loss could be the result of 
a temporary imbalance between one or more collagenolytic 
enzymes and their natural inhibitors, virtually no data were 
available on the presence of collagenolytic enzymes in 
intestinal anastomoses. Therefore, we have investigated the 
occurrence of such enzyme activity in the early phase of 
anastomotic healing in the rat intestine. 
COLORECTAL CANCER 
Colorectal cancer is a major cause of death in the 
industrialized world. Figures released by the WHO estimate 
a total of 570000 new cases worldwide in 1992 [22] . 
Environmental as well as genetic factors have been 
associated with the development of large bowel cancer. Large 
bowel cancer is clearly linked to environmental factors: 
people living in parts of Africa and Asia have a very low 
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incidence of this cancer whereas in the industrialized 
countries it is one of the most common types of cancer. The 
incidence of colorectal cancer in the general population 
increases rapidly with age. Peak incidence in both man and 
woman occurs in the 8th decade of life. The direct 
relationship of age with the incidence of cancer is 
generally believed to result from the cumulative effects of 
carcinogens on colonic cells over a long period of time. If, 
however, colorectal cancer appears in the first decades of 
life usually predisposing factors such as familial polyposis 
syndromes or ulcerative colitis are involved [23]. 
Most colorectal cancers develop from benign adenomas 
(polyps) in what is referred to as the adenoma to carcinoma 
sequence [24]. The progression of colorectal cancer is a 
multistage process, thought to depend on an accumulation of 
mutations in a number of genes [25,26]. Cytogenetic analysis 
has shown that most cancers are chromosomally abnormal and 
that both oncogenes and tumour suppressor genes are involved 
in carcinogenesis (reviewed in [27]). As a consequence of 
the genetic alterations the control of cell proliferation 
and the preservation of normal structural associations 
(cell-cell and cell-matrix) are disrupted, thereby creating 
an environment where normal intercellular interactions may 
be changed. 
A biologically and clinically important difference 
between benign and malignant colorectal tumours is the 
ability of the latter to attack extracellular matrices by 
releasing tissue destructive enzymes. This provides the 
means for local expansion (invasion) and spreading to 
distant organs (metastasis) [28,29]. In order to move from 
the primary site to metastatic sites tumour cells have to 
cross through several connective tissue barriers. Perhaps 
the most important of these is the basement membrane that 
underlies the endothelial cells of the vascular system. 
Enzymes belonging to all the major enzyme classes, the 
aspartic-, serine-, metallo-, and cysteine- proteinases are 
potentially involved in invasion and metastasis due to their 
ability to degrade one or more extracellular matrix 
proteins, activate an enzyme capable of doing so, or 
inactivate proteinase inhibitors. Latest insights actually 
propose the concerted action of enzymes of different classes 
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involved in a so called proteolytic cascade. 
Metalloproteinases such as type IV collagenase and 
stromelysin have been strongly implicated in the proteolytic 
aspect of the invasive process [30,31]. 
Recently, it was shown for the first time that a tumor 
cell membrane-associated receptor exists for type IV 
collagenase [32] . Previously, the existence of a urokinase-
type plasminogen activator receptor had been identified on 
the outer membrane surface of tumor cells [33]. 
Liotta [28] identified the three main steps in invasion 
and metastasis as an initial process of attachment of tumour 
cells to the basement membrane (phase 1) followed by 
proteolysis of the local connective tissue stroma (phase 2) 
and finally the migration of tumour cells through the 
proteolyzed stroma (phase 3). biotta's model has recently 
been refined by Mareel et al. [34] who have included factors 
regulating homo- and hetero-typic cell-cell adhesion 
dynamics. 
An important regulatory mechanism in the control of 
proteolytic activity is the presence of specific proteinase 
inhibitors. Loss of inhibitor activity by whatever mechanism 
invokes a situation that resembles the loss of tumour 
suppressor genes which will eventually result in an 
increased malignant potential. A detailed examination of 
tumor-associated proteolytic events may help to reveal the 
fundamental mechanisms of tumour invasion and metastasis and 
disclose possible drug targets. The potential role of 
interstitial collagenase (MMP-1) has been studied in matched 
tumour and control samples from a large number of patients 
diagnosed for colorectal cancer. The results of this study 
are presented in chapter 5. 
THE BIOLOGY OF COLLAGEN: A BRIEF REVIEW 
One of the unique properties of multicellular organisms 
is their organization of cells into cooperative clusters 
which, when combined, form macroscopical functional units 
called organs. The cells within tissues are supported by and 
in close contact with an extended network of extracellular 
18 
macromolecules : the extracellular matrix (ECM). 
Extracellular matrices determine body shape and stability, 
compartmentalization of organs and several cellular 
activities. The more commonly used term, connective tissue, 
refers to the ECM plus the cells found in it. The major 
cell-type found in the ECM is the fibroblast, responsible 
for the production of the majority of the extracellular 
macromolecules. In highly specialized connective tissue 
structures the ECM is secreted by more specific fibroblast-
like cells such as chondrocytes which form the deformable 
cartilage matrix and osteoblasts which produce the rigid 
bone matrix. Additional specialized ECM structures are found 
in tendons, cornea, basement membranes, fasciae and teeth. 
The wide interest in ECM research today has been preceded 
by a period of absolute ignorance, due to a general belief 
that the ECM served mainly as an inert physical stabilizer 
of tissues. The regulatory role of the ECM and its cellular 
components influencing cellular development, proliferation 
and differentiation of cells, cell motility and metabolism 
in health and disease, is now generally recognized and a 
topic of research worldwide. 
The main classes of extracellular macromolecules that 
make up the ECM are collagens, proteoglycans, elastin, 
fibronectin and laminin. 
Within the framework of this thesis attention will be 
limited to the collagens. For detailed information on the 
other matrix components the reader is referred to some 
recent reviews [35-40]. 
The collagens are a family of highly characteristic 
(glyco)-proteins, present throughout the animal kingdom. 
They are the most abundant of mammalian proteins, being 
distributed throughout the body and constituting 25 to 30 
per cent of total body protein. 
So far, a family of thirteen distinct collagen molecules, 
composed of at least 25 polypeptide chains, have been 
recognized and characterized to varying degrees [41-43] 
(Figure 3). The remarkable feature of this collagen 
superfamily is its varied repertoire of molecular structures 
and patterns of supermolecular assembly. The fibrillar 
collagen types I, II, III and V and the non-fibrillar 
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Figure 3 ; Molecular structure of the collagen types. Collagens 
contain triple-helical (solid and open rods) and globular domains 
(open and filled circles) . Portions of the initially synthesized 
molecules are removed prior to their incorporation into insoluble 
matrices (open rods and circles) and the rest of the molecule 
remains intact in the matrix (closed circles and rods). The 
domains and their distribution are drawn approximately to scale. 
From: Burgeson RE and Nimni ME. Collagen types: Molecular 
structure and tissue distribution. Clin. Orthopaedics 282: 250-
272, 1992 (with permission) 
collagen type IV, which is specific for basement 
membranes, were the first to be identified and their complex 
biosynthesis and structure have been elucidated to a large 
extent. 
COLLAGEN STRUCTURE 
The basic structure of collagen as a protein with three 
polypeptide chains has been established in the late 
nineteen-fifties. All known collagens contain two distinct 
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types of structural domains: the triple helical domain and 
the globular domains. Three lefthanded helical polypeptide 
chains, called α-chains, each of which comprises about 1,000 
amino acid residues, are coiled around each other in a stiff 
right-handed supercoil. The amino acid sequence of the 
polypeptide chains is unique in that every third residue is 
glycine and that it possesses the regularly repeating tri-
peptide Gly-X-Y. With very few exceptions proline (Pro) is 
always present in the X position and hydroxyproline (Hyp) 
prevails in the Y position. The Gly-Pro-Hyp sequence makes 
up about 10% of the entire molecule [42,43]. 
The helix comprises one complete turn for about every 
three residues. This conformation is made possible by the 
absence of side chains on the glycine residues. The hydroxyl 
groups of the hydroxyproline residues form strong inter­
chain hydrogen bonds thus stabilizing the triple helix. 
Hydroxyproline and hydroxylated lysine residues, 
hydroxylysine, are relatively specific to collagen. 
Glycosylation of the collagen molecules is exclusively 
through the hydroxylysine residues. Short non-helical 
peptide sequences, called telopeptides, at the NH2- an COOH-
terminal ends are characteristic for the of-chains of native 
collagen molecules. The telopeptides are regarded to be 
essential for the formation of inter-chain and inter-
molecular crosslinks. 
COLLAGEN BIOSYNTHESIS 
The biosynthesis of (pro)collagen proceeds according to 
the general principles of synthesis of secreted proteins. 
The collagene are synthesized as precursor forms or 
procollagens containing N- and C-terminal extensions on 
their peptide chains. A simplified scheme for the 
biosynthesis of interstitial collagens is indicated in 
Figure 4. While elongation of the amino acid chains is still 
in progress, prolyl and lysyl residues are hydroxylated and 
hydroxylysyl residues become glycosylated. Hydroxylation of 
proline and lysine residues is quite unique for collagen 
proteins. The extent of these modifications are mediated by 
the primary structure of the peptide backbone which 
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Figure 4 : Schematic drawing of the various intracellular and 
extracellular events involved in the formation of the collagen 
fibril. From: Chapter 12, pp 673-715, Cell-cell adhesion and the 
extracellular matrix. In: The molecular biology of the cell. 
Alberts В., Bray D., Lewis J., Raff M., Roberts K. and Watson 
J.D. (eds.). Garland Publishing Inc. New York and London, 19Θ3. 
(with permission) 
determines the folding of the peptide chains during 
synthesis. It thus controls post-translational processes by 
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limiting the access of modifying enzymes to only a few 
specific sites. Hydroxylation and glycosylation can only 
take place before the triple helix is formed. Between 
cysteine residues present in both the NH2-terminal and COOH-
terminal extensions interchain disulphide bonds are formed. 
Disulphide bond formation in the telopeptides is thought to 
guide the chain assembly and final folding of the triple 
helical procollagen molecules . After triple-helix formation 
is completed within the cisternae of the endoplasmatic 
reticulum, the procollagens are rapidly translocated through 
the Golgi-complex towards the plasma membrane. Subsequently, 
the newly synthesized procollagen molecules are released 
into the extracellular space where they encounter a number 
of processing enzymes and undergo fibril formation and 
crosslinking [43] . 
The extracellular procollagens are processed to collagen 
by the partial removal of the NH2- and COOH-terminal 
extensions. The enzymes are procollagen N-proteinases and 
procollagen C-proteinases and lysyl oxidase. All the 
procollagen proteinases isolated so far are neutral, 
calcium-dependent metalloproteinases [44] . The N-terminal 
extensions are removed prior to the C-terminal extensions. 
The intermediate procollagen without a NH2-propeptide is 
referred to as Pc-collagen. Consistently, Pn-collagens 
(procollagen molecules with a removed COOH extension, but 
with an intact NH2 extension) are rarely observed. Pn-
collagens are occasionally reported as a result of a genetic 
disorder, which has been shown to have an impact on collagen 
biosynthesis e.g. in dermatosparaxis and osteogenesis 
imperfecta [45-48] . 
Lysyl oxidase initiates cross-linking in collagens by 
oxidative deamination of certain lysine and hydroxylysine 
residues located in the short N- and C-terminal non-triple 
helical regions (called telopeptides) [49] . Under 
physiological conditions the resultant triple-helical 
molecules, called tropocollagens, are resistant to further 
degradation by proteases other than specific collagenases. 
The tropocollagen molecules spontaneously assemble into a 
precisely arranged packing pattern, the collagen fibril. 
Initially, collagen fibrillogenesis is a reversible process 
but the formation of covalent crosslinks within and between 
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constituent tropocollagens gradually strengthens the newly 
formed fibrils. 
The biosynthesis of the collagen or-chains, their intra-
and extracellular modifications and the final assembly of 
tropocollagen into fibrils requires the activity of a wide 
spectrum of enzymes. Inappropriate functioning of these 
enzymes, either caused by a structurally changed target site 
on the (pro)-collagen molecules, or by a deficiency of an 
enzyme or one of its cofactors, have been incriminated in 
many "collagen-associated diseases". A structural defect in 
the amino terminus of the pro-orl(I) chain of type I 
procollagen, resulting in the loss of the N-proteinase 
cleavage site, was shown to be responsible for the type VII 
form of the Ehlers-Danlos syndrome [50] . In scurvy, a human 
disease caused by a dietary deficiency of ascorbic acid 
(vitamin С is one of the cofactors of the enzyme prolyl-
hydroxylase), the insufficient hydroxylation of proline 
inhibits procollagen helix formation as a result of which 
the skin and blood vessels become extremely fragile [51] . 
Single base changes in the codons for glycine account for 
most of the mutations, which reflects the strict 
stereochemical requirement for glycine at every third 
position in the collagen triple helix [45] . Genetic 
disorders of collagen biosynthesis usually affect tissues 
in which the proper development and integrity of connective 
tissues is of paramount importance. Hence, the majority of 
these disorders affect bone (osteogenesis imperfecta), skin 
and joints (Ehlers-Danlos syndrome), arteries (Marfan 
syndrome) and cartilage development. Comprehensive 
information on a number of genetic disorders affecting 
collagen proteins can be found in references [45,52,53]. 
DEGRADATION OF COLLAGENS 
Regulation of collagen homeostasis is not only confined 
to its biosynthetic pathway but is also controlled by, 
inhibitor modulated, enzymatic degradation. Degradation of 
extracellular matrix components is a prerequisite action in 
many normal physiological processes. When a tissue undergoes 
rapid remodelling, as observed in early development of long 
bones, in the postpartum uterus or in wound healing where 
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abrupt physiological changes in tissue mass occur, the rate 
of collagen removal is rapid and extensive [54]. 
Two important pathways of collagen breakdown have been 
studied in detail during the last decades: an intracellular 
one and an extracellular one [55,56] . In vivo, both pathways 
might be simultaneously active and complementary to each 
other. However, intracellular degradation of collagen 
appears to be restricted to physiological turnover and 
remodelling [57-59], while extracellular breakdown is more 
frequently observed under pathological conditions as in 
rheumatoid arthritis [60-62] and during tumor cell invasion 
[63,64] . 
INTRACELLULAR DEGRADATION OF COLLAGEN 
Intracellularly degraded collagen has been shown to be 
of both intra- and extra-cellular origin. Evidence for the 
"breakdown-before-secretion" concept of newly synthesized 
procollagen molecules have been provided by time-course 
experiments of Laurent and co-workers [57,59] and Bienkowski 
and colleagues [65,66]. Berg and co-workers [67] 
demonstrated that cultured lung fibroblasts induced to 
synthesize abnormal procollagen, were capable of shunting 
a portion (up to 18 per cent) of such procollagen to their 
lysosomes for intracellular digestion. 
The intracellular degradation of collagen from the 
extracellular space, necessitates the phagocytosis of 
collagen fibrils by connective tissue cells. It has been 
suggested, that prior to their uptake these fibrils are 
somewhat digested by extracellular collagenolytic enzymes 
[68,69]. However, Everts et al. [70] demonstrated a 
mammalian collagenase-independent uptake of collagen fibrils 
in cultured periosteal expiants. 
Both phagocytosed fibrils and non-secreted defective 
procollagen molecules are digested in the lysosomal 
apparatus. The existence of a lysosomal route of 
collagenolysis was supported by Etherington [71,72] and 
Burleigh et al. [73] who demonstrated the degradation of 
both soluble and insoluble collagen by the lysosomal enzymes 
cathepsin В and collagenolytic cathepsin. More recently, 
Kirschke and Barrett [74] showed that two other lysosomal 
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enzymes, the cysteine-proteinases cathepsin L and N, are 
potent collagenolytic enzymes. All the enzymes mentioned 
here only function at rather acid Ph which limits their 
activity to the small, acidified, intracellular compartments 
of phagocytic cells. However .there is some evidence that 
a specially generated acidic environment outside the cell, 
e.g. at the membrane/fibre interface, permits some of the 
acid proteinases to attack extracellular collagen fibrils 
[75]. Local pericellular acidification down to pH values 
where these enzymes can operate has recently been 
demonstrated [76-78] . 
EXTRACELLULAR DEGRADATION OF COLLAGEN 
The irreversible extracellular breakdown of connective 
tissues and especially its collagenous component has been 
subject of extensive research during the last decades. The 
supposed role that collagenolytic enzymes may play in many 
inflammatory diseases, in wound healing and tumour invasion 
and metastasis undoubtedly has had its impact on its current 
scientific attention [79-81]. 
The enzymatic mechanisms whereby collagen is degraded, 
other than by the attack of bacterial collagenases, 
generally involves the cooperative action of a number of 
enzymes. In vitro, collagen has been shown to be degraded 
as a whole, or in part, by enzymes representing all four 
classes of proteinases. Several degradation schemes have 
been proposed which include at least three or four different 
steps [82,83]. 
In general, we can distinguish the following steps: 
1) depolymerization of collagen fibres 
2) physiological collagenolysis 
3) further extracellular breakdown of collagen-derived 
peptides. 
1] DEPOLYMERIZATION 
Prior to the action of true mammalian collagenases 
(enzymes which attack the helical core of native collagen 
molecules under physiological conditions) a depolymerisation 
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of the polymeric collagen fibres is considered necessary 
[84] . Two mechanisms of depolymerization have been 
suggested. The first proposes the cleavage of the cross­
links in the telopeptides [85,86]. A second mechanism 
assumes the existence of a proteolytic attack on the non-
helical carboxyterminal telopeptide between the helix and 
Procol laoenaie 
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Figure S : Proco l lagenase a c t i v a t i o n and i t s i n t e r a c t i o n w i th 
c o l l a g e n . Modif ied from: M i g n a t t i P . , Welgus H.G. and R i f k i n D.B. 
Role of d e g r a d a t i v e enzymes i n wound h e a l i n g . C h a p t e r 2 1 , pp 
497-524. I n : The M o l e c u l a r and C e l l u l a r B i o l o g y of Wound R e p a i r . 
C l a r k R.A.F. and Henson P . M . ( e d s ) . Plenum P u b l i s h i n g Coop. New 
York, 19ΘΘ. (with p e r m i s s i o n ) 
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its nearest lysyl residue, which is known to be important 
in the formation of intermolecular cross-links [87,88]. For 
both mechanisms candidate enzymes have been proposed. 
Starkey et al. [89,90] suggested that both elastase and 
cathepsin G derived from polymorphonuclear leucocytes could 
destabilize collagen fibrils. The leucocyte enzymes are 
thought to play a substantial role in collagen destruction 
in inflamed connective tissues [91,92]. 
A telopeptidase, with all the characteristics of a 
metallo- proteinase, described by Goldberg and Scott [88] 
was isolated from porcine gingiva expiants and shown to be 
active under similar conditions as interstitial collagenase . 
Although a partial solubilization of the collagen 
molecules at the surface of the fibrils certainly would 
facilitate the action of a true collagenase by increasing 
its susceptibility, it is not yet clear if this is merely 
a supportive or an elementary step in collagen degradation. 
2] PHYSIOLOGICAL COLLAGBNOLYSIS 
The subsequent, crucial, step in the proposed collagen 
degradation scheme is the hydrolysis of the triple helix . 
A schematic drawing of the extracellular degradation of 
collagen by mammalian collagenases is given in Figure 5. The 
triple helical structure of native fibrillar collagene 
(Types I, II and III) is extremely resistant to the action 
of most digestive proteases. However, a closely related 
group of enzymes, the vertebrate collagenases, do attack the 
helical core at one very specific locus - a point 
approximately three-quarters of the length of the molecule 
from its amino-terminal end. The cleavage products, 
designated TCa (75%) and TCb (25%) , can be separated 
electrophoretically from their native or-chains and are 
regarded as the ultimate evidence for the presence of a true 
mammalian collagenase. 
Essentially all of the known mammalian collagenases 
appear to cleave the collagen helix at the same locus, i.e, 
Gly-Ile in the αϊ chain of type I collagen and Gly-Leu in 
the a2 chain (positions 775-776 in the amino acid sequence) 
[93] . The first enzyme described with such a unique 
specificity was isolated from the culture medium of tadpole 
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tail tissue [94] . Since its first detection similar enzymes 
have been isolated from the culture medium of a large number 
of cells and tissues obtained from a variety of species. The 
cells include fibroblasts, keratinocytes, macrophages, 
polymorphonuclear leucocytes and tumour cells [95-99]. 
Recent data suggest that there are two immunologically and 
kinetically distinct interstitial collagenases, one secreted 
by connective tissue cells and macrophages and another 
stored exclusively in PMN-leucocyte granules, which are 
released during degranulation [98-100] . 
3] EXTRACELLULAR BREAKDOWN OF COLLAGEN-DERIVED PEPTIDES 
The fragments formed by the action of collagenase, 
comprising the amino-terminal three-quarter and the carboxy-
terminal one-quarter of the molecule dissociate from the 
fibril, spontaneously lose their helical conformation in 
vitro at 37°C and denature to gelatin. The structurally less 
complex gelatin chains are susceptible to degradation by 
less specific proteases. Although very highly purified 
collagenases can degrade gelatins at a low rate, gelatin is 
generally regarded as a relatively poor substrate for 
interstitial collagenase [101]. 
A specific group of enzymes, present in the extracellular 
space, where they are synthesized by a variety of connective 
tissue cells [102] , and in secretory granules of neutrophils 
[103], has been demonstrated to preferentially degrade 
gelatin at neutral pH and collectively has been referred to 
as gelatinases. Subsequently, both the tissue and PMN-
leucocyte gelatinases were demonstrated also to degrade 
native and soluble type IV and V collagen [104-106]. 
Recent studies have shown the existence of two 
immunologically distinct gelatinases, with very similar 
substrate specificities migrating at either a molecular 
weight of approximately 72 kDa or 92 Kda in SDS-PAGE 
[107,108]. The high molecular weight, glycosylated, 
gelatinases are secreted by macrophages, monocytes and 
neutrophils and by some tumour cells. Connective tissue 
cells predominantly secrete the lower, mainly non-
glycosylated, molecular weight species. A type IV collagen 
degrading enzyme from tumour cells and transformed 
29 
connective tissue cells [109], referred to as type IV 
collagenase, was reported to be immunologically related to 
the gelatinases produced by circulating cells [110]. 
Sequence homology between the type IV collagenase and the 
low M
r
 gelatinase of connective tissue cells was 
demonstrated by Collier et al. [Ill]. Latter studies have 
further strengthened the hypothesis that all the gelatinases 
and type IV collagenases described to date are closely 
related proteinases which merely differ in their degree of 
glycosylation. 
The small fragments that remain after gelatinase action 
are further degraded both extracellularly by peptidases as 
well as intracellularly in the catheptic phago-lysosomal 
pathway. 
DEGRADATION OF BASEMENT MEMBRANE COLLAGEN TYPE IV 
The basement membranes collagenous matrices separate the 
parenchymal cells of various tissues from underlying 
interstitial stroma. Basement membranes limit the 
penetration of macromolecules through blood vessel walls, 
act as a scaffold for epithelial cells and promote cell 
differentiation [35,38,112]. 
The major collagenous component of basement membranes is 
type IV collagen and is distinct from the other types as 
judged by location and chemical and immunological criteria. 
Collagen type IV is not attacked by the interstitial 
collagenases [112]. This basement membrane collagen type is 
degraded by an altogether different set of proteases. A type 
IV collagen degrading enzyme was first isolated from the 
culture medium of a highly metastatic mouse tumour expiant 
by Liotta and colleagues [113]. The type IV collagenase 
described by this group cleaved the type IV collagen 
molecule within the helical domain but failed to degrade 
type V collagen. Type IV collagen molecules are cleaved in 
a similar fashion as the interstitial collagens generating 
a three-quarter С terminal and a one-quarter N-terminal 
fragment [114] . Now, most of the gelatinolytic enzymes 
purified from mesenchymal cells, tumour cells, macrophages 
and PMN-leucocytes have been assessed for their potential 
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activity against type IV collagen. From these studies it 
became clear that the 72 Kda gelatinase and type IV 
collagenase activity is essentially the activity of a single 
enzyme exhibiting minor inter-tissue and species differences 
[98,99,115] . 
Nome» Deduced Nr of [CM Substrates 
Mass (kDo) Domains 
COLLRGENRSES 
Interstitial collagenase (EC 3.4.24.7) 
MMP-1, fibroblast collagenase 
Neutrophil collagenase (EC 3.4.24.34) 
54.1 
53.4 
Collagen types I, I I , 
I I I , UH and H 
Collagen types I, III 
and III 
GELATINÖSES 
Gelatinose R (EC 3.4.24.24) 
MMP-2, 72 kD gelatinase 
type ID collagenase 
Gelatinase В (EC 3.4.24.35) 
MMP-9, 92 kD gelatinase, 
92 kD type IV collagenase 
73.9 
78.4 
Gelatins, collagen IU 7, 
U and elaslln 
Gelatins, collagen ID?, 
II and elaslln 
STROMELVSINS 
Stromelysln-1 (EC 3.4.24.17) 
MMP-3, transln, proteoglycanase 
procollagenase actluator 






collageni I I I , IV, U, IH 
Proteoglycans, Ismlnln, 
flbronectin, gelatins, 
collagens I I I , IU. U, IH 
Matrllysln (EC 3.4.24.23) 
MMP-7, Pump-1, uterine 
metalloprotelnase 
29.7 Proteoglycans, gelatins 






53.9 elaslin, fibronectln 
Table I; Characteristics of the Matrix Metalloproteinase family 
members. From: Matrisian L.M. The matrix-degrading metallo-
proteinases. BioEssays 14: 455-463, 1992. (with permission) 
THE MATRIX METALLOPROTEINASES 
Both the interstitial collagenases and 72 Kda gelatinase 
A (type IV collagenase) are endopeptidases and have been 
classified as matrix metalloproteinases. This group of 
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proteinases also includes the enzyme stromelysin-1 
(originally called proteoglycanase [98,99,116] and at least 
two other metalloproteinases with a strong preference for 
extracellular matrix proteins as substrates. Thus, the 
matrix metalloproteinases (also referred to as matrixins or 
MMP's) are generally considered to be key enzymes in 
extracellular matrix turnover [115,117,118] . Stromelysin-1 
is a particularly remarkable enzyme in that it is active 
over a wide pH range (5.0 - 9.0) and degrades a broad range 
of substrates. This proteinase is now regarded as one of the 
most important catabolic enzymes of the ECM, synthesized and 
secreted by the very same connective tissue cells that 
produce the matrix. 
The properties of the three major MMP subclasses -
collagenases, gelatinases and the stromelysins - vary little 
with species and cell type; all appear to cleave their 
collagenous substrates at a Gly-Leu or Gly-Ile peptide bond. 
Characteristics common to most of the matrix 
metalloproteinases are presented in Table I. 
The recent elucidation of the primary amino acid sequences 
of rabbit synovial collagenase [119], human fibroblast 
collagenase [120,121], human stromelysin-1 [122] and 
stromelysin-3 [123] and the rat stromelysin homologues 
transin and transin-2 [124,125] revealed extensive sequence 
homologies between these enzymes and confirmed their 
proposed relationship [126]. Conserved features include two 
cysteine residues present in the active form of the enzymes, 
a zinc chelation site and two potential glycosylation sites. 
In gelatinase A the catalytic domain is split by a 
fibronectin binding domain, while gelatinase В has an 
additional collagen binding domain. 
THE BIOLOGICAL REGULATION OF METALLOPROTEINASE ACTIVITIES. 
Modulation of extracellular matrix degradation can take 
place by control of the synthesis and secretion of 
metalloproteinases, by control of the factors responsible 
for activation of the latent metalloproteinases, by control 
of the amount of inhibitor(s) synthesized and secreted and 
by control of the removal of the metalloproteinases and/or 
inhibitors in the extracellular space. Figure б summarizes 
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the main events associated with the proteolytic degradation 
of the extracellular matrix. 
PROTEINASES 
Neutral pH acting (around pH 7.0) 
Metalloproteinascs: Gelatinases 
Stromelysin, Collagenase. 
Serine proteinases: Plasminogen 
activators, Plasmin and Elastase 
Acid pH acting (between pH 3 and 6) 
Cysteine proteinases: Cathepsin В and L 
Aspartic proteinases: Cathepsin 0 
INHIBITORS 
1.METALL0PR0TEINASES: TIMP'S 
2. CYSTEINE PROTEINASES: CYSTATINS 
3. PLASMINOGEN ACTIVATORS: PAI-1 AND PAI-2 
4. GENERAL: alpha 2 Macroglobulin, alphalPI 
Figure 6 ; Schematic drawing of the secretion, activation and 
inhibition of proteinases potentially involved in the degradation 
of the extracellular matrix. 
REGULATION OF MATRIX METALLOPROTEINASE EXPRESSION 
A significant feature of cells secreting 
metalloproteinases and their inhibitors (Tissue Inhibitor 
of Metalloproteinase: TIMP) is their extreme sensitivity to 
soluble stimuli such as hormones, growth factors, vitamins 
33 
and tumor promotors (e.g. phorbol esters). It is thought 
that the effect of these regulating factors on the 
metalloproteinases and their inhibitors determines the 
integrity of the extracellular matrix in both health and 
disease. Treatment of synovial and cartilage expiants in 
culture with corticosteroids suppressed the production of 
MMP's [127,128] . Burnett et al. [129] reported, a significant 
increase of TIMP sputum levels in patients with chronic 
bronchitis after treatment with prednisolone. Progesterone 
was shown to regulate the activity of collagenase and the 
gelatinases A and В in human endometrial expiants [130]. 
Matsusue and Walser [131], using adrenalectomized rats, 
showed that corticosterone plasma levels are to be kept 
within confined limits in order to accomplish proper 
intestinal anastomotic healing. 
Corticosteroids, shown to be capable of regulating both MMP 
and TIMP production might thus be important in matrix 
remodelling as observed in diseased joints and during wound 
healing. 
A number of reports have shown that the cytokine 
interleukin-lß (IL-lß) is a very potent inducer of MMP-1 
(collagenase) and/or MMP-3 (stromelysin) [132-135]. Although 
IL-lß did not alter the expression of the 72kD gelatinase 
(MMP-2) [136] it did induce the 92kD form (MMP-9) in 
synovial fibroblasts allowing these cells to degrade MMP-1 
and MMP-3 resistant interstitial elements such as collagen 
types IV, V and XI [133]. Meikle et al. [137,138] showed 
that the cytokines IL-1 and tumor necrosis factor a (TNF-of) , 
released from circulating mononuclear cells, could induce 
collagenolysis of periodontal tissues in a dose-dependent 
manner while total TIMP levels remained unchanged. In vivo 
production of these cytokines is believed to be induced by 
bacterial antigens. 
The cellular response to IL-lß was subsequently shown to 
be either up- or down-modulated by other growth factors. The 
platelet derived growth factor (PDGF), which was also found 
to be synthesized and released from activated macrophages 
[13 9], exhibited a synergistical response towards IL-lß 
induction of MMP-1 and MMP-3 [140] . On the other hand it was 
demonstrated by several groups that transforming growth 
factor-beta (TGF-ß) can control the effects of several other 
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growth factors such as IL-lß, IL-2, epidermal growth factor 
(EGF) and basic fibroblast growth factor (bFGF) [141-143] 
on MMP secretion. TGF-ß, a stimulator of the synthesis and 
deposition of extracellular matrix components, may perform 
this function by selectively repressing the IL-1 induction 
of MMP's by reducing the number of IL-1 receptors [132] but 
also by simultaneously enhancing the expression of TIMP 
[143,144]. In addition, TGF-ß can directly exert its effect 
on the synthesis of new collagen by regulating a gene 
crucial for the production of this molecule [145]. 
Another representative of the interleukin family, IL-6, 
did not modify MMP-1 expression but was shown to induce the 
synthesis of TIMP-1 in a number of connective tissue cells 
[146] . The cytokine 11-4 caused a dose-dependent suppression 
of macrophage 92-kD gelatinase (MMP-9) production without 
affecting TIMP levels [147]. At the same time it was shown 
that IL-4 blocked the synthesis of MMP-9 by human monocytes 
via a prostaglandin-E2 linked mechanism [148]. 
TNF-a and EGF enhanced the steady state levels of the 
messenger for MMP-1 [149] but were also found to act at the 
protein level since an increase in the secretion of this 
enzyme was observed [150] . The binding of TNF-a to high 
affinity receptors profoundly affected gene regulation and 
stimulated e.g. the IL-1 and IL-6 genes [151] an effect not 
unexpected from the 'boss' of the cytokines. 
ACTIVATION OF METALLOPROTEINASE PROENZYMES 
Normal levels of metalloproteinase activities in 
unstimulated cell or expiant culture systems are below or 
near the detection limit of activity-based assays. This 
finding is due to their secretion as latent enzymes and 
their instant capture by inhibitors present in serum. 
Activation is thought to be a key point in the regulation 
of matrix metalloproteinase activity and has been the 
subject of several studies. In vitro activation of 
metalloproteinases derived from connective tissue cells can 
be accomplished by addition of organomercurials, such as p-
Aminophenylmercuric acetate (АРМА) and p-Chloromercuric-
benzoic acid (pCMB), by surfactants such as sodium 
dodecylsulphate (SDS) or by disulfide compounds such as 
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oxidized glutathione. These modes of activation of latent 
collagenase involve the dissociation of cysteine residue 73 
(Cys73) from the active-site zinc atom and its replacement 
by water. This process is referred to as the "cysteine 
switch", with the concomitant exposure of the active site 
(Figure 7) [152,153]. Others support the theory that 
activation occurs by means of a stepwise loss through 
proteolysis of an Mr 9000 propeptide from the N-terminus of 
the native molecule [154,155]. One of the later steps in 
this cascade was shown to be autocatalytic. Conformational 
perturbations induced under denaturing conditions (АРМА, low 
pH, SDS and an increased temperature) might disrupt the 
propeptide functions and thus be sufficient to activate. 
Figure 7 : Model describing the underlying biochemical basis for 
the multiple modes of activation of latent human fibroblast 
collagenase. From: Springman et al. Multiple modes of activation 
of latent human fibroblast collagenase: Evidence for the role of 
a Cys73 active site zinc complex in latency and a cysteine switch 
mechanism for activation. Proc. Natl. Acad. Sci. USA 87: 364-368, 
1990. (with permission) 
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The mechanisms underlying the in vivo activation of these 
enzymes are still poorly understood. Limited proteolysis by 
trypsin, plasmin, neutrophil elastase and cathepsin G are 
established methods to activate metalloproteinases in a test 
tube [156] . Unlike collagenase and stromelysin, gelatinase 
is poorly activated by exogenous proteinase action [102-
104]. A mechanism for which some experimental support has 
been obtained is the involvement of a proteolytic cascade, 
similar to blood coagulation [157] . An important step in the 
in vivo activation of metalloproteinases might be the 
generation of plasmin from its zymogen plasminogen by 
plasminogen activators [158-160]. Plasminogen activation 
possibly involves the cysteine proteinases cathepsin В and 
L [161,162] . Furthermore, it appears that metalloproteinases 
can activate each other: recently stromelysin was shown to 
significantly enhance the activity of an MMP-1 preparation 
[163,164] . 
INHIBITION OF METALLOPROTEINASES 
Metalloproteinases are subject to inactivation by the 
serum inhibitor a2-macroglobulin and an expanding family of 
tissue inhibitors of metalloproteinases (TIMPs) [165]. 
Activated collagenase is inactivated by formation of a 1:1 
complex with the tissue inhibitor of metalloproteinases. 
TIMP is a heat stable sialoglycoprotein of approximately 2 8 
Kda and contains six disulfide linkages [166]. TIMP can be 
destroyed by reduction and alkylation [166] , lacks species 
specificity but does not inhibit bacterial collagenases. The 
inhibitory activity of TIMP against MMP-1, 2, and 3 was 
almost completely abolished by reacting the inhibitor with 
either trypsin, a-chymotrypsin or PMN-leucocyte elastase. 
Cathepsin G and pancreatic elastase showed less degradative 
effects on TIMP [167] . A non-glycosylated inhibitor, IMP or 
TIMP-2 was later isolated from a complex with the 72 Kda 
progelatinase A [168]. However, the complex of MMP-2 with 
TIMP-2 does not inhibit its gelatinolytic activity 
suggesting that binding is distant from the active centre 
of the enzyme [169] . TIMP-2 was shown to be capable of 
inhibiting the autocatalysis of gelatinase A but another 
molecule of either TIMP or TIMP-2 was required to inhibit 
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gelatinolysis [170] . A third member of the family (ChIMP-3) 
exclusively located in the matrix was recently isolated from 
chicken embryo fibroblasts [171] . 
The ability of TIMPs to inhibit not only collagenase but 
other MMP's as well suggests an important role in the 
regulation of ECM degradation. TIMP synthesis and secretion 
appears to be executed by the same cells that are known to 
secrete metalloproteinases thus requiring a tightly 
controlled coordination. 
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AIM OF THE STUDY 
The understanding of the balance between synthesis and 
degradation of collagen in the healing intestine has been 
one of the long term objectives of the research undertaken 
in the Department of General Surgery. Indirect evidence 
suggests that an imbalance between a collagenolytic enzyme 
and its natural inhibitor might be causative to disturbed 
anastomotic repair. However, experimental data on 
collagenolytic enzyme activities in intestinal wounds are 
lacking. Therefore, we have investigated the putative role 
in wound healing of an essential enzyme in the degradation 
of collagen, the metalloproteinase collagenase. To this end 
methods were developed to extract and assay enzymatic 
activity present in experimental anastomoses, using the rat 
as a model. Anastomoses were constructed simultaneously in 
both ileum and colon so that we would be able to correlate 
our data with the clinical observation that healing of 
colonic wounds on average poses more problems than an ileal 
wound. Furthermore, we have attempted to purify the enzyme 
collagenase (MMP-1) from the culture medium of rat and human 
derived skin fibroblasts. This work was started in order to 
obtain pure enzymes for subsequent immunohistochemical 
studies. In addition, a comparison between the rat and human 
enzyme was thought to be useful in the interpretation of 
data obtained from our rat model and in extrapolating to the 
human situation. 
Since a large number of colorectal anastomoses in 
patients is constructed following the excision of neoplastic 
growth and the processes of wound healing and tumor cell 
invasion show remarkable similarities, we have also 
investigated the activity of collagenase in human tumour 
specimen and matched non-invaded mucosal tissue obtained at 
surgery. Collagenolytic activities were correlated with both 
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ABSTRACT 
The post-operative degradation of collagen has been 
postulated to play an important role in the development of 
anastomotic leakage in the intestine. However, 
collagenolytic activity in intestinal anastomoses has hardly 
been studied so far. We have measured collagenolytic 
activity, after extraction in an urea-containing medium, in 
both ileal and colonic anastomoses in the rat, from 12 hours 
to 31 days after operation. 
In ileum collagenolytic activity increased significantly, 
from 2 to 4 (average 2.7) times the control value, at 12 
hours post-operatively followed by a steady decline to 
original levels. Four weeks after surgery the activity was 
still slightly, but significantly, enhanced. In colon 
collagenolytic activity also increased up to 4 times the 
pre-operative level (average 3.0) 12 hours after operation. 
Return to original levels was delayed in colon compared to 
ileum but here activities were similar to control values 
after one month. In both parts of the intestine there was 
only a small increase in activity at a segment proximal to 
the anastomosis during the first 24 hours after operation. 
The amount of protein extracted did not vary significantly 
between control and anastomotic samples. These data are the 
first to show a transiently increased extractable 
collagenolytic activity in intestinal anastomoses. 
INTRODUCTION 
A major complication of surgery of the large bowel is 
anastomotic leakage. Despite improved surgical techniques 
healing of colonic anastomoses is disturbed rather 
frequently (Fielding et al., 1980), resulting in leakage of 
luminal content into the abdominal cavity and thereby in 
high mortality and morbidity. The molecular mechanisms 
underlying this phenomenon still need elucidating in order 
to find ways of diminishing its frequency. 
The tensile strength of the intestinal wall is provided 
mainly by its connective tissue layer, the submucosa, which 
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is composed almost entirely of collagen (Gabella, 1987; 
Thomson et al., 1986). During the first post-operative days 
anastomotic strength depends solely on the suture holding 
capacity of the existing collagen fibres in the submucosa. 
Apart from its function as a structural protein, collagen 
plays a crucial role in the process of wound healing, e.g. 
inducing coagulation and acting as a chemoattractant for 
fibroblasts. It has been shown that collagen concentrations 
around experimental intestinal anastomoses change massively 
during the first post-operative days, certainly in the colon 
(Cronin et al.,1968; Jiborn et al, 1980) and, to a lesser 
extent, also in the ileum (Hesp et al.,1984; Hendriks et 
al., 1985). These experimental data are taken as evidence 
for the existence of a 'collagenous equilibrium' which is 
crucial to anastomotic healing (Hunt et al., 1980) : after 
anastomotic construction collagenolysis occurs followed by 
de novo collagen synthesis. If collagen degradation is 
increased or if synthesis is delayed or its rate too low, 
restoration of the collagen lattice takes too long and 
chances for anastomotic leakage increase. Therefore, an 
understanding of the post-operative collagenolytic process 
and the enzymes involved, both under normal healing 
conditions and under circumstances which favour anastomotic 
dehiscence (Khoury and Waxman, 1983), appears necessary 
since restriction of collagen degradation might improve 
intestinal healing. As a first step, we describe the 
existence of a transient increase in collagenolytic 
activity, extractable from intestinal anastomoses in the 
rat. 
MATERIALS AND METHODS 
Operative Techniques. 
Male Wistar rats with an average weight of 220 g (range: 
180-280 g) were used. All animals received both an ileal and 
a colonic anastomosis. Surgery was performed under 
semi-sterile conditions using a Zeiss operating microscope. 
Rats were brought under general anaesthesia by an 
intraperitoneal injection of sodium pentobarbital. The 
abdomen was opened through a midline incision of 
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approximately 4 cm. Ileal anastomosis: a small bowel segment 
1-2 cm in length, the per-operative control segment, was 
resected at a distance of 15 ± 3 cm proximal to the 
ileal-caecal junction (Fig 1:C). An end-to-end anastomosis 
was constructed using θ single layer inverting interrupted 
8 x 0 Ethilon" sutures (Ethicon, Norderstedt, FRG) . 
Figure 1: Schematic drawing of the intestinal tract of the rat. 
Arrows indicate the resection sites. A: Per-operative control 
segment and anastomosis in large intestine. B: Postoperative 
control segment in large intestine. C·. Peroperative control 
segment and anastomosis in small intestine. D: Postoperative 
control segment in small intestine. 
Colonic anastomosis : an 1 cm long segment (per-operative 
control) of the descending colon 3 cm proximal to the 
peritoneal reflection (Fig 1:A) was removed. Continuity was 
restored as in ileum. The abdomen was closed in two layers 
using silk for the fascia and staples for the skin. 
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After 12 hours (n=6) and 1 (n=7), 2 (n=9), 3 (n=7), 7 
(n=ll) and 31 (n=6) days the animals were sacrificed by 
means of an intracardial overdose of sodium pentobarbital 
and the anastomoses (1 cm) were collected together with 
post-operative control segments located at approximately 15 
cm proximal (Fig 1:D) to the ileal anastomosis and 7 cm 
proximal (Figl:B) to the colonic anastomosis, respectively. 
Resected tissue segments were opened longitudinally, washed 
twice in ice-cold physiological salt solution, dried and 
frozen in liquid nitrogen until further processing. 
Preparation of the extract. 
Extracts of bowel segments with or without an anastomosis 
were prepared essentially according to the method of Wirl 
(1977). Briefly: 100 mg of sample, pulverized in a Braun 
microdismembrator, was suspended in 2 ml of 10 mM Tris-HCl 
(pH 7.5), containing 0.4 M sucrose and 5 mM CaCl2 and 
subsequently rotated for 30 min. Tissue was pelleted by 
centrifugation at 9000 χ g for 15 min and washed twice 
again. The final sediment was extracted for 2 h with 5 M 
urea in 50 mM Tris-HCl (pH 7.5), containing 0.2 M NaCl and 
5 mM CaCl2. After centrifugation at 40000 χ g for 30 min the 
supernatant was dialysed for 16 h against the same buffer 
without urea to produce a final urea concentration less than 
20 mM. All procedures were performed at 4 °C. 
Assay of Collagenolytic Activity. 
Collagenolytic activity was assayed by measuring the 
release of radioactive material from [14C] collagen type I 
in solution. Pure type I collagen was prepared from pepsin 
solubilized fetal calf skin, after salt fractionation at 
neutral pH (Miller and Rhodes, 1982) and labelled with [14C] 
acetic anhydride according to Cawston and Barrett (1979) . 
Labelled collagen (0.60-1.00 μΟϊ/τηΙ) was dialysed 
exhaustively against 0.1 M acetic acid in a 50000 D 
Spectra/Por 6 membrane prior to storage at -30°C. 
Assays were carried out in fivefold in 1.5 ml microtubes : 
50 μΐ intestinal extract was added to 20 μΐ [14C] collagen 
(2 mg/ml) and 200 μΐ 50 mM Tris-HCl (pH 7.8), containing 50 
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гаМ СаС12 ,0.5 M NaCl; 50 μΐ of dialysis buffer (see previous 
section) was added to control tubes. The reaction was 
allowed to proceed for 4 h at 37 °C and subsequently 
terminated by the addition of 50 μΐ 50 mM Tris-HCl (pH 7.8) , 
containing 0.2 M EDTA. After re-incubation at 40°C for 15 
min, to allow denaturation of degradation products, 100 μΐ 
of 5 M NaCl/glacial acetic acid (9:1, v/v) was added and 
caps were placed on ice for at least 30 min (Seng et 
al.,1984) . The tubes were centrifugated at 10000 χ g for 10 
min and 100 μΐ of the supernatant was added to 5 ml Aqua 
Luma (Lumac BV, Landgraaf, The Netherlands) and counted in 
a liquid scintillation analyzer. Preliminary studies showed 
enhancement of the collagenolytic activity by addition of 
АРМА, which compound is known to activate latent 
(pro)collagenase (Stricklin et al.,1983) . АРМА was therefore 
routinely included in the assay buffer in a final 
concentration of 1 mM. 
After subtracting the blank, which routinely constituted 
4-6% of total counts present, activities were expressed in 
mU per mg of original wet weight or as mU per mg protein, 
1 U representing degradation of 1 дд collagen/min under the 
conditions stated. 
The amount of protein extracted was assayed according to 
Lowry et al. (1951) using bovine serum albumin as a standard. 
Methods used for statistical evaluation of the data are 
given together with results in the appropriate section. 
RESULTS 
The urea-based extraction procedure yielded reproducible 
amounts of solubilized protein from both small and large 
intestine (Table I) . The amounts of protein extracted were 
similar in colon and ileum. On the whole, variations between 
animals with respect to protein extracted from per-operative 
control segments were such, that no significant differences 
were found between the groups of animals to be sacrificed 
at the various time points. However, for some unknown reason 
the yield from the six rats which were to be sacrificed at 
31 days, was lower than in the other groups. Little 
difference was found between per-operative control segments 
and anastomotic samples. Although mean values of the amount 
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of protein extracted from control samples were generally 
higher than those obtained from anastomoses, differences 
were limited and only significant in a few cases. 
Table I; Protein levels in extracts from per-operative control 
segments and anastomotic segments in the experimental groups. 
Average values (± S.D.) are expressed as μg/mg tissue wet weight. 
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 Significant (0.01 < ρ < 0.05 ; Wilcoxon signed rank test) 
difference between anastomosis and control segment. 
Table II: Collagenolytic activity in extracts from previously un­
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44.8 ± 24, 
53.1 ± 29, 
35.2 ± 20, 
39.2 ± 12, 
41.6 ± 21. 



















total 4 6 51.6+23.8 2.4 ± 1.1 39.3 ± 22.5 1.7 ± 1.0 
Collagenolytic activity in the urea extracts from bowel 
biopsies was expressed as mU per mg wet weight used for 
extraction or as mU per mg of protein extracted. Similar 
results were found in both cases. Table II shows the 
activities extracted from the control tissue segments 
resected at operation, presumably representing uninjured 
intestine. All assays were performed in the presence of 
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¡VPMA. If АРМА was omitted from the incubation there was 
•aardly any activity detectable in colonic samples. Addition 
Df АРМА resulted in measurable activities in almost all 
intestinal samples: in 4 out of 46 cases collagenolytic 
activity was not detectable in per-operative colon control 
samples but was measurable in the anastomotic and 
Dost-operative segments. The effect of АРМА stimulation on 
ileal extracts was less pronounced, indicating an increased 
amount of active enzyme in these extracts. Here, measurable 
activities were found in all extracts also if АРМА was 
Dmitted. Other extraction procedures (Curry et al., 1986,-
îeckhout et al.,1986) were also performed but yielded less 
activity. 
Basal activities appear to be somewhat higher in ileum 
:han in colon. Clearly, a large inter-animal variation 
occurs. Thus, it is important to compare post- and 
эег-operative activities within one animal, each rat serving 
ÍS its own control. 
Figures 2 and 3 depict, for each rat, the ratio between 
inastomosis and per-operative control (A) and the ratio 
jetween post-operative control and per-operative control (B) 
m ileum and colon, respectively. The values shown were 
:alculated on the basis of activities expressed as mU/mg 
)rotein extracted. Figures where data were calculated from 
ictivities per mg wet weight used for extraction are very 
similar and consequently not shown. Clearly, more 
:ollagenolytic activity could be extracted from anastomotic 
:issue than from uninjured intestine. The average increase 
it each post-operative time point is given in table III. In 
.leum, collagenolytic activity was elevated significantly 
irom 12 hours to 31 days after operation. The increase was 
lost pronounced in the first post-operative period. A 
similar trend was found in colon. Here, activities extracted 
:rom 31 days-old anastomoses were no longer higher than 
.hose extracted from the corresponding per-operative control 
segments. Collagenolytic activities in the post-operative 
:ontrol segment from ileum were at no time point 
¡ignificantly different from those extracted from the 
)er-operative control segment (Fig 2B) . In colon, 
:ollagenolytic activity in the post-operative control 
¡egment was significantly elevated at 12 and 24 hours after 
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Figure 2 ; Figure 3 : 
Figure 2 : Relative changes in collagenolytic activity in ileum 
during the first month after operation. Values are expressed as 
the ratio between activity extracted from the anastomosis and the 
activity extracted from the peroperative control segment (A) and 
the ratio between activities extracted from the post-operative 
and the peroperative control segment, respectively (B) . Separate 
points represent measurements within one rat. 
Figure 3 ; Relative changes in collagenolytic activity in colon 
during the first month after operation. See legend Figure 2. 
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Table III: Increased collagenolytic activity in anastomotic 
extracts. The average ratio of activity extracted from the 
anastomosis in relation to activity extracted from the 
per-operative control segment is given (+ S.D.) Ratios are based 
on enzyme activities in mU/mg protein. 
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Level of significance was calculated using Wilcoxon's signed rank 
test. 
DISCUSSION 
It is generally accepted that repair of the collagenous 
interstitial network is an essential feature of the wound 
healing sequence (Forrest, 1983). Since tissue collagen 
levels are a net result of the separate processes of 
collagen degradation and collagen synthesis, the balance 
between the two processes is of importance to the healing 
wound. Collagen degradation after injury has been 
investigated much less than collagen biosynthesis. Attempts 
to improve intestinal healing by influencing anastomotic 
collagen metabolism should be preceded by characterization 
of the separate processes of collagen degradation and 
synthesis in this particular tissue. 
Only a few reports exist concerning collagenolytic 
activity in uninjured intestine (Oyamada et al.,1983 ;Lewin 
et al.,1986; Irimura et al.,1987). Since we encountered 
great difficulties in preventing massive growth of bacteria 
in expiants from rat intestine, we limited our present 
efforts to the measurement of activity in extracts from 
intestinal tissue. Table II shows that collagenolytic 
activity was indeed present in urea-extracts from both ileum 
and colon. Although the activities measured are small, and 
the labelled collagen blank in the assays may comprise up 
to 50% of total counts released, the sensitivity of the 
method is sufficient to detect even relatively small 
changes. It should be emphasized that all assays were run 
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in the presence of АРМА and thus represent the sum of latent 
and active enzyme activities. While under our assay 
conditions degradation of type I collagen is probably not 
mediated exclusively by true collagenases (Birkedal-Hansen 
,1987), the fact that activities are enhanced by the 
presence of АРМА and inhibited by both EDTA and 1,10-
O-phenanthroline [van der Stappen: unpublished results] 
indicates the involvement of a metalloproteinase. 
The occurrence of collagenolysis during the healing of 
intestinal anastomoses has been taken for granted (Hunt et 
al., 1980; Khoury and Waxman, 1983) . Still, with the exception 
of the work of Hawley et al. (1970) , who reported increased 
collagenolytic activity in colonic anastomoses 3 days after 
operation as measured by a semi-quantative lysis assay, no 
experimental data concerning possible mechanisms of this 
process had been available. Our results prove that 
extractable collagenolytic activity is significantly, and 
transiently, increased after operation. Very recently, 
Chowcat et al. (1988), in an immunohistochemical study 
using monoclonal antibodies, showed the presence of 
extracellular collagenase in rabbit colonic anastomoses. The 
essence of their results corresponds quite well with our 
data, despite the obvious difference in methodology, the 
species difference and the fact that they constructed 
everted anastomoses, which are hardly ever used in 
intestinal surgery. 
The activities measured do not necessarily reflect the 
actual increase in collagenolytic potential in anastomotic 
tissue. It seems quite possible that the injury-induced 
increase in collagenolytic activity we measured is 
underestimated because a substantial part of the enzyme 
molecules could have been bound by TIMP and thus escape 
detection (Reynolds, 1985). Since immunohistochemistry 
indicates the precise location of antigens but does not 
allow conclusions regarding their actual activity, we feel 
that our data are complementary to those reported by Chowcat 
et al. (1988) and not merely confirm their very recent 
findings. Moreover, our study has shown that changes in 
collagenolytic activity also, and to the same extent, occur 
in ileal anastomoses where the clinical frequency of leakage 
is far below that reported for the large bowel. 
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The present results, which show an increased capacity for 
collagen degradation during the first week after 
construction of intestinal anastomoses in the rat, support 
the hypothesis that the decreased collagen concentrations 
measured before around colonic (Jiborn et al.,1980) and 
ileal (De Roy van Zuidewijn et al. ,1986) anastomoses in this 
animal, indeed reflect a process of collagen breakdown. It 
should be emphasized that our system, based on established 
surgical procedures, is one of the few existing which 
enables the study of tissue degrading processes under 
non-pathological conditions. It remains to be established 
which enzymes are involved. We are currently applying lower 
temperatures, fibrillar substrates and specific inhibitors 
in the assay of anastomotic extracts in order to confirm the 
presumed participation of an active collagenase. Thereafter, 
this system will be used to study the postulated increase 
of collagenolytic capacity in anastomoses, constructed under 
conditions which increase chances for anastomotic 
dehiscence. Such research appears essential in order to find 
measures to limit anastomotic leakage. 
Footnotes : EDTA : Ethylenediaminetetraacetic acid ; АРМА : 
p-Aminophenyl-mercuric acetate ; TIMP : Tissue Inhibitor of 
Metalloproteinases. 
LITERATURE. 
Birkedal-Hansen, H.: Catabolism and turnover of collagene: 
collagenases. Methods in Enzymology 144, 140-171, 1987. 
Cawston, Т.Е. and Barrett ,A.J.: A rapid reproducible assay for 
collagenase using 14C acetylated collagen. Anal. Biochem. 99: 
340-345, 1979. 
Chowcat,N.L., Savage,F.J., Hembry,R.M. and Boulos,P.B.: Role of 
collagenase in colonic anastomoses: a reappraisal. Br. J. Surg. 
5: 330-334, 1988. 
Cronin, K., Jackson, D.S. and Dunphy, J.E.: Changing bursting 
strenght and collagen content of the healing colon. Surg. 
Gynecol. Obstet. 126: 747-753, 1968. 
Curry, Т.Е., Clark, M.R., Dean, D.D., Woessner, J.F. and LeMaire, 
W.J.: The preovulatory increase in ovarian collagenase activity 
in the rat is dependent of prostaglandin production.Endocrinology 
118: 1823-1828, 1986. 
Eeckhout, Y., Délaissé, J.-M. and Vaes, G. : Direct extraction and 
assay of bone tissue collagenase and its relation to parathyroid 
-hormone-induced bone resorption. Biochem. J. 239: 793-796, 1986. 
Fielding, L.P., Stewart-Brown, S., Blesovsky, L. and Kearney, G. 
Anastomotic integrity after operations for large-bowel cancer: 
a multicentre study. Br. Med. J. :411-414, 1980. 
66 
Forreet, L. : Current concepts in soft connective tissue wound 
healing. Br. J. Surg. 70: 133-140, 1983. 
Gabella, G.: The cross-ply arrangement of collagen fibres in the 
submucosa of the mammalian small intestine. Cell Tissue Res. 
248: 491-497, 1987. 
Hawley, P.R., Faulk, W.P., Hunt, Т.К. and Dunphy, J.E.-. 
Collagenase activity in the gastro-intestinal tract. Br. J. 
Surg.57: 896-904, 1970. 
Hendrike, Th., геескеп, T.H.L.B., Hesp, W.E.L.M., Schillings, 
F.H.M, and Boer de, H.H.M.: Loss of collagen from experimental 
intestinal anastomoses : early events. Exp. Mol. Pathol. 42: 
411-418, 1985. 
Heep, W.L.E.M., Hendrike, Th., Lubbers, E.J.C, and Boer de, 
H.H.M.: Wound healing in the intestinal wall. A comparison 
between experimental ileal and colonic anastomoses. Dis. Colon 
Rectum 27:99-104, 1984. 
Hunt,Т.К., Hawley,P.R., Male,J., Goodson,W., Thakral,K.K. : Wound 
healing and wound infection, ed. by Hunt,Т.К., 
Appleton-Century-Crofts, New York, 1980, pp 153-159. 
Irimura, T., Yamori. T., Bennett, S.C., Ota, D.M. and Cleary, 
K.R. : The relationship of collagenolytic activity to stage of 
human colorectal carcinoma. Int. J. Cancer 40: 24-31, 1987. 
Jiborn, H., Ahonen, J., Zederfeldt, В.: Healing of experimental 
colonic anastomosis III collagen metabolism in the colon 
after left colon resection. Am. J. Surg. 139: 398-405, 1980. 
Khoury, G.A. and Waxman, B.P.: Large bowel anastomoses. I. The 
healing process and sutured anastomoses- a review. Br. J. Surg. 
70, 61-63,1983. 
Lewin, M.R., Chowcat, N.L., Jáyaraj, A.P. and Boulos, P.B. : 
Collagenase inhibition in colonic mucosa by proteinase 
inhibitors. Br. J. Exp. Path. 67: 523-526,1986. 
Lowry, O.H., Roeebrough, N.J., Farr, A.L., Randall, R.J.: Protein 
measurement with the folin phenol reagent. J. Biol. Chem. 193: 
265-275, 1983. 
Miller, E.J. and Rhodes, R.K.: Preparation and characterization 
of the different types of collagen. Methods in Enzymology 82A: 
33-64, 1982. 
Oyamada, I., Kitaoka, M., Araki, C , Yoshioka, H. and Ueuku, C.: 
Collagenase from the culture medium of rabbit-colon wall, with 
special reference to the latent type and substrate specificity. 
Gastroenterology 85: 376-384,1983. 
Reynolds, J.J.: The molecular and cellular interactions involved 
in connective tissue destruction. Br. J. Dermatol. 112: 715-723, 
1985. 
de Roy van Zuidewijn, D.B.W., Wobbes, Th., Hendrike, Th., 
Klompmakers, A.A. and Boer de,H.H.M. : The effect of 
antineoplastic agents on the healing of small intestinal 
anastomoses in the rat. Cancer 58: 62-66, 1986. 
Seng, W.L., Davison, P.F. and Kenyon, K.R.: A simple vertebrate 
collagenase assay using soluble radioactive collagen substrate. 
Anal. Biochem. 139: 17-24, 1984. 
Stricklin, G.P., Jeffrey, J.J., Roswit, W.T. and Eisen, A.Z.: 
Human skin fibroblast pro collagenase: mechanism of activation 
by organomercurials and trypsin. Biochemistry 22: 61-68, 1983. 
Thomson, H.J., Busuttil, Α., Eastwood, M.A., Smith, A.N. and 
Elton, R.A.:The submucosa of the human colon.J. Ultrastruc. Mol. 
67 
Struc. Res. 96: 22-30, 19Θ6. 
Wirl, G.: Extractable collagenase and carcinogenesis of mouse 
skin. Connect. Tiss. Res. 5: 171-178, 1977. 
68 
CHAPTER 3 
COLLAGENOLYTIC ACTIVITY IN EXPERIMENTAL INTESTINAL 
ANASTOMOSES 
Differences between small and large bowel and evidence 
for the presence of collagenase. 
Jos W.J. van der Stappen, Thijs Hendriks, Herman H.M. de 
Boer, Ben M. de Man and Jan Joep H.H.M, de Pont 
Int. J. Colorect. Dis. 7: pp 95-101, 1992 
ABSTRACT 
Collagen degradation is thought to be an integral part 
of the healing sequence of intestinal anastomoses, but 
almost nothing is known about the enzyme activities 
involved. We have studied collagenolytic activities, 
extracted from 1 day-old intestinal anastomoses in the rat. 
Using either soluble type I collagen or fibrillar type I or 
type III collagen as a substrate, activities measured in 
extracts from anastomotic segments were compared to those 
in extracts from uninjured intestine, removed at operation: 
in all cases, the collagenolytic activity in anastomotic 
extracts was higher. This increase was significantly more 
pronounced in large bowel than in small bowel. The 
activities were strongly inhibited by serum and metallo-
chelating compounds. Analysis, by means of SDS-polyacryl-
amide gel electrophoresis, of the reaction products of the 
degradation of fibrillar type I collagen by the extracts 
revealed the presence of a multitude of fragments, amongst 
them TCA fragments characteristic for the activity of 
mammalian collagenase. Thus, the degradative capacity 
towards various collagen substrates is enhanced in the 
anastomotic area during the first postoperative period and 
a true mammalian collagenase is one of the enzymes present. 
INTRODUCTION 
Anastomotic leakage remains one of the major 
complications of gastro-intestinal surgery. This phenomenon 
occurs relatively frequently in the large bowel [1] , while 
leakage of small bowel anastomoses is rarely observed [2]. 
Clinically manifest leakage rates for colonic anastomoses 
have been reported to be as high as 14% [3]; inspection by 
X-rays of extraperitoneal anastomoses even revealed leakage 
rates of up to 51% [4]. 
The necessity of including the submucosa, as the major 
structural layer of the intestinal wall, in the suturing of 
the bowel ends was recognized a century ago [5] . This layer 
is made up almost entirely of collagen [6,7] and therefore 
collagen metabolism is crucial to anastomotic strength [Θ] . 
After anastomotic construction, collagen degradation is 
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thought to take place to some extent, as a consequence of 
the inflammatory reaction which is an essential part of the 
normal wound healing sequence. Infiltrating neutrophils, 
characteristic for early inflammation, could be involved in 
this process. They comprise not only a potent source of 
collagen degrading enzymes, such as collagenase and 
gelatinase, but are also known as an important source of 
collagenase activators [9] . 
Since sutures have to be anchored primarily in the 
submucosal collagenous network, degradation of collagen 
fibrils may weaken anastomotic strength, sometimes resulting 
in anastomotic dehiscence. Under certain conditions, e.g. 
the presence of infection, collagen degradation may become 
more extensive leading to diminished strength and enhanced 
risk of anastomotic rupture [10]. Therefore, an 
understanding of the degradative processes involved appears 
necessary to find ways to prevent this type of complication 
in intestinal surgery. 
Very little is known about the process of collagen 
degradation around intestinal anastomoses. Its occurrence 
may be derived from post-operative changes in collagen 
concentration and content [11-13] but so far its mechanism 
has hardly been investigated. Early experiments by Hawley 
et al. [14] suggested the participation of collagenolytic 
enzymes and, very recently, the presence of collagenase 
activity was indeed demonstrated immunohistochemically in 
colonic anastomoses of the rabbit [15] . In a previous study 
we have reported the presence of collagenolytic activity in 
extracts from rat intestinal anastomoses [16]. This 
activity, which is transiently increased after operation, 
was measured using soluble collagen as a substrate, leaving 
the possibility that it originates from non-specific 
proteases. In the present paper, we further characterize 
this collagenolytic activity by using fibrillar collagen 
substrates. 
MATERIAL AND METHODS 
Operation 
Male Wistar rats with an average weight of 200 ± 25 gram 
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received both an ileal and a colonic anastomosis after 
resection of a 1 cm long segment (peroperative control). 
Surgical procedures were as previously described [16] . End-
to-end anastomoses were constructed microsurgically, using 
single-layer inverting interrupted sutures ( 8 x 0 
monofilament polyamide, Ethilon") , approximately 15 cm 
proximal to the ileal-caecal junction and 3 cm proximal to 
the peritoneal reflection, respectively. After 24 h the 
animals were killed by means of an overdose of sodium 
pentobarbital and the anastomotic segments (approximately 
1 cm) were collected. Resected segments were opened 
longitudinally, washed thoroughly with ice-cold 
physiological salt solution, dried and frozen in liquid 
nitrogen until further processing. 
Extraction 
Extracts of bowel segments with or without an anastomosis 
were prepared essentially according to Wirl [17] . Briefly: 
100 mg of sample, pulverized in a Braun microdismembrator, 
was suspended in 2 ml of 10 mM Tris-HCl (pH 7.5) containing 
0.4 M sucrose and 5 mM CaCl2 and subsequently rotated for 3 0 
min. Tissue was sedimented by centrifugation at 9000 χ g for 
15 min and washed twice again. The final sediment was 
extracted for 2 h with 5 M urea in 50 mM Tris-HCl (pH 7.5) , 
containing 0.2 M NaCl and 5 mM CaCl2. After centrifugation 
at 40000 χ g for 30 min the supernatant was dialysed for 16 
h against the same buffer without urea. All procedures were 
performed at 4°C. 
Analytical procedures 
Collagenolytic activity was measured both in a soluble 
assay using 14C-labelled type I collagen and in two assays 
using 14C-labelled reconstituted type I and type III 
fibrils, respectively, as a substrate. Collagenolytic 
activity was determined by measuring the release of 
radioactive material from the collagen substrates. Type I 
collagen used in the soluble assay and type III collagen 
used in the fibrillar assay were purified from 
pepsin-solubilized fetal calf skin. Type I collagen used in 
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the fibrillar assay was purified from the acid-soluble 
fraction of fetal calf skin. The collagens were purified by 
differential salt fractionation at neutral pH [18] and 
labelled with [14C]-acetic anhydride (25mCi/mmol, Amersham, 
UK) [19] . 
Labelled collagens were dialysed exhaustively against 0 .1 
M acetic acid in a 50000 D Spectra/Por 6 membrane prior to 
storage at -3 0°C. The soluble assays was performed as 
previously described [16]. For fibrillar assays, collagen 
type I or III solutions in acetic acid were neutralized by 
dialysis against 30 mM Tris-HCl (pH 7.3), containing 30 mM 
Na2HP04.2H20 and 135 mM NaCl. Aliquote of 20 μΐ neutralized 
collagen solution were applied to each well of a 96 wells 
plastic tissue culture plate (Greiner High Affinity plates; 
Greiner, Alphen a/d Rijn, The Netherlands) and allowed to 
gel for 1 h in a humidified atmosphere at 37°C [20]. After 
gelling the plates were air-dried in a laminar flow hood. 
Dried plates were washed twice with demineralized water to 
remove remnants of buffer. 
Assays were carried out in triplicate: 50 μΐ of the 
extracts and 150 μΐ of 50 mM Tris-HCl (pH 7.8), containing 
50 mM CaCl2 and 0.5 M NaCl were applied to each well. The 
reaction was allowed to proceed for 22 h at 37°C in a 
humidified atmosphere to avoid evaporation. At the end of 
the incubation period the whole content of each well was 
transferred into microtubes and centrifuged at 10000 χ g for 
10 min. A 100 μΐ sample of the supernatant was mixed with 
3 ml of Aqua Luma (Lumac BV, Landgraaf, The Netherlands) and 
counted in a liquid scintillation analyzer. The 
organomercurial p-aminophenylmercuric acetate (АРМА) was 
routinely added to the incubations in a final concentration 
of 1 mM in order to activate latent collagenase. In some 
experiments, protease inhibitors were added to the assay 
buffer for characterization purposes: Soybean trypsin 
inhibitor was purchased from Sigma, St. Louis, USA; 
Phehylmethylsulphonylfluoride (PMSF) was obtained from 
Serva, Heidelberg, FRG; Trasylol (aprotinin) was obtained 
from Bayer, Leverkusen, FRG; Tissue inhibitor of 
metalloproteinases TIMP was a gift from Dr. G. Murphy from 
Strangeways Research Laboratory, Cambridge, UK). 
Collagenolytic activities were expressed as mU per mg of 
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original wet weight or as mU per mg protein extracted, 1 U 
representing the degradation of 1 ^ g collagen/min under the 
conditions stated. 
For sodium dodecylsulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) , extraction volumes (4 ml/100 mg 
of pulverized tissue) obtained from anastomoses from 4 rats 
were pooled and concentrated to approximately 500 μΐ. 
Fibrillar type I assay supernatants from 6 wells, obtained 
after incubation of 75 μΐ concentrated extract with 225 μΐ 
assay buffer and 20 μΐ [14C] labelled collagen for 72 h at 
28°C, were collected and pooled. The pools were dialysed 
overnight against demineralized water and lyophilized. 
Lyophilized material was separated by SDS-PAGE using 10 or 
8% Polyacrylamide [21]. Protein bands were visualized by 
standard autoradiography. 
The amount of protein extracted was assayed according to 
Lowry et al. [22] using bovine serum albumin as a standard. 
Statistical methods are mentioned with the results. 
RESULTS 
The collagenolytic activity in the urea extracts from 
bowel biopsies was calculated on the basis of both mg wet 
weight used for extraction (Table 1) and mg protein 
extracted (Table 2) . Both approaches revealed similar 
results. The existence of large inter-animal variations, 
apparent from the relatively high standard deviations, 
emphasizes the necessity of comparing anastomotic and 
control values within the same animal. Basal activities in 
uninjured intestine, i.e. activities extractable from the 
control segments, were higher in ileum than in colon. 
Statistical evaluation proved this to be the case in all 
three assays employed. 
Figure 1 shows the post-operative change in 
collagenolytic activity for each rat, calculated as the 
ratio between activities measured in anastomotic and control 
segments. Despite the fact that each animal acted as its own 
control, great variations were found between animals. 
Collagenolytic activity extracted from colonic anastomoses 
was, in almost all rats, higher than the activity measured 
in extracts from the control segments. This effect was less 
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Table 1 : Collagenolytic activity, expressed on the basis of wet 
weight, extractable from control and anastomotic segments. 
Average values (± S.D) are expressed as mU/mg wet weight. 
SUBSTRATES 
Soluble Fibril Fibril 
type I type I type III 
Ileum 
Control 2.30 ± 0.70 2.04+0.90 1.58 ± 0.83 
(n= 27) (n= 24) (n= 23) 
Anastomoses 2.68 ± 0.73 2.54 ± 1.17 1.67 ± 0.80 
(n= 27) (n= 24) (n= 24) 
Colon 
Control 1.86 ± 0.77 1.24 ± 0.73 1.08 ± 0.62 
(n= 27) (n= 22) (n= 23) 
Anastomoses 2.46 + 0.62 1.80 ± 0.80 1.35 ± 0.70 
(n= 26) (n= 23) (n= 23) 
p-value* 0.0010 0.0001 0.0001 
The p-value of the difference between ileal and colonic control 
samples was calculated using Wilcoxon's signed rank test. 
Table 2 : Collagenolytic activity, expressed on the basis of 
protein, extractable from control and anastomotic segments. 
Average values ( + S.D) are expressed as mU/mg protein extracted. 
SUBSTRATES 
Soluble Fibril Fibril 
type I type I type III 
Ileum 
Control 68.2 ± 20.5 60.2+27.3 45.2+2.8 
(n= 27) (n= 24) (n= 24) 
Anastomoses 81.3 ± 24.4 73.2 ± 28.4 47.9 ± 21.1 
(n= 27) (n= 24) (n= 24) 
Colon 
Control 58.2 ± 23.1 38.3 ± 22.1 32.2 ± 16.3 
(n= 27) (n= 22) (n= 24) 
Anastomoses 90.3 ± 26.8 62.5+25.1 44.9 ± 20.6 
(n= 26) (n= 23) (n= 24) 
p-value* 0.0237 0.0002 0.0003 
The p-value of the difference between ileal and colonic control 
samples was calculated using Wilcoxon's signed rank test. 
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Figure 1. Relative change in collagenolytic activity extractable 
from 1 day-old intestinal anastomoses. Collagenolytic activity 
was measured using soluble collagen type I (A) , fibrillar type 
I (B) and fibrillar type III (C) as a substrate. Values are 
expressed as the ratio between the activity extracted from the 
anastomosis and the activity extracted from the per-operative 
control segment. Separate points represent measurements within 
one rat. 
pronounced in ileum. The increased activity in anastomotic 
extracts , measured before using a soluble substrate, was 
also found when fibrillar substrates were employed. The 
average increase in anastomotic collagenolytic activity was 
calculated, both if activities were expressed on a wet 
weight basis (Table 3) and if activities were expressed on 
a protein basis (Table 4 ) . 
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Table 3 ; Post-operative increase in collagenolytic activity 
measured if activities are expressed on the basis of wet weight. 
The ratio between activities extracted from anastomotic and 
control segments, calculated for each rat, is given as the 
average ± S.D. 
SUBSTRATES 
Soluble Fibril Fibril 
type I type I type III 
Ileum Ratio 1.19 ± 0.09 1.32 ± 0.51 1.10 ± 0.19 
(n= 27) (n= 24) (n= 24) 
p-value* 0.0001 0.0068 0.0116 
Colon Ratio 1.61 ± 1.11 1.76 ± 0.85 1.43 ± 0.51 
(n= 26) (n= 21) (n= 22) 
p-value 0.0001 0.0010 0.0002 
Difference 
ileum/colon 
p-value* 0.00Θ4 0.0762 0.0082 
p-values were calculated using Wilcoxon's signed rank test. 
Table 4 : Post-operative increase in collagenolytic activity 
measured if activities are expressed on a protein basis. The 
ratio between activities extracted from anastomotic and control 
segments, calculated for each rat, is given as the average ± S.D. 
SUBSTRATES 
Soluble Fibril Fibril 
type I type I type III 
Ileum Ratio 1.22 ± 0.30 1.31 ± 0.52 1.11 ± 0.20 
(n= 27) (n= 24) (n= 24) 
p-value* 0.0059 0.0140 0.0158 
Colon Ratio 1.73 ± 0.82 2.01 ± 0.88 1.62 ± 0.81 
(n= 26) (n= 21) (n= 22) 
p-value* 0.0001 0.0004 0.0002 
Difference 
ileum/colon 
p-value* 0.0006 0.0239 0.0061 
p-values were calculated using Wilcoxon's signed rank test. 
Statistical analysis of these data revealed a significant 
increase in collagenolytic activity measured in the extracts 
of 1-day-old anastomotic segments compared to that measured 
in extracts from the peroperative controls. This effect was 
observed with all the three substrates and independent of 
the manner in which activity was expressed. In addition, the 
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increase was significantly more pronounced in colonic than 
in ileal anastomoses. 
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Figure 2. SDS-Polyacrylamide gel electrophoresis of the lysis 
products obtained from the incubation (72 h at 28°C) of Re­
labelled fibrillar type I collagen with anastomotic extracts. 
Solubilized material was lyophilized and applied to a 10% 
Polyacrylamide gel; protein bands were visualized by 
autoradiography. Lanes А, С and E: lysis products produced by 
colon anastomotic extracts from three different rats. Lanes B,D 
and F: lysis products produced by the corresponding ileal 
anastomotic extracts. Lane G : control type I collagen. Molecular 
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Figure 3 : SDS-Polyacrylamide gel electrophoresis of the lysis 
products obtained from the incubation (72 h at 28°C) of Re-
labelled fibrillar type I collagen with rat anastomotic extracts. 
Solubilized material was lyophilized and applied to a 8% 
Polyacrylamide gel; protein bands were visualized by 
autoradiography. Lane A: type I collagen; lanes В and D: lysis 
products produced by ileal anastomotic extracts from two 
different rats; lanes С and E: lysis products produced by the 
corresponding colonic anastomotic extracts; lane F: lysis 
products obtained from an incubation (22 h at 28°C) of collagen 
type I fibrils with purified human fibroblast collagenase, 
showing the characteristic TCA a,(I)A and a2(I)A fragments 
respectively. Molecular weight values are given to the left of 
the gel. 
In order to characterize the collagenolytic activity in 
the intestinal extracts we have separated the reaction 
products of the degradation of fibrillar type I collagen by 
means of SDS-polyacrylamide gel electrophoresis. In Fig. 2 
the intact substrate and its lower molecular weight lysis 
products are visualized by autoradiography. Lysis products 
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can be seen between the intact dimers (ß-chains) and 
monomers (α-chains) and between the monomers and the dye 
front. The smallest lysis products which were retarded by 
the 10% Polyacrylamide gel ran together with the tracking 
dye. Reaction products characteristic f or purified mammalian 
collagenases, the Ύ,Α and TCB fragments, are difficult to 
identify on this autoradiogram. However, by decreasing the 
Polyacrylamide concentration in the gel to 8% and including 
lysis products obtained from an incubation of purified human 
fibroblast collagenase as reference proteins, characteristic 
degradation products representing 75% of the α-chain length 
(the IVA fragment) could be identified (Fig. 3). Smaller 
protein fragments were identifiable on both autoradiograms 
and appear to be the result of a progressive degradation, 
possibly caused by less specific proteases. Extracts from 
ileal tissues show more intermediate lysis products than 
their corresponding colonic tissues (Figure 2) . On the 
contrary, extracts of the latter tissue produced more 
smaller fragments, as can be seen on the dye front, 
suggesting a more extended and faster lysis of the larger 
intermediates. Extraction buffer alone did not solubilize 
any collagenous material from the fibrillar gels (results 
not shown). 
Table 5 : Effects of inhibitors on extracted collagenolytic 
activity. Results are expressed as average percentage residual 
activity ± S.D. 
Inhibitor or Ileal η Colonic η 
procedure Anastomoses Anastomoses 
None 100 100 
Calcium-free buffer 49 ± 9 5 51 ±13 5 
EDTA 120 mM 47 ± 13 4 40 ± 15 4 
O-phenanthroline 6 mM 51 ± 10 3 49 ± 9 3 
PMSF 2 mM 108 ±14 3 108 1 
Trasylol 100 мд/ті 66 1 72 1 
SBTI 100 μg/ml 71 1 102 1 
Fetal calf serum 5% 1 9 + 6 4 20 ± 4 3 
hrTIMP 5U/ml 90 ± 12 5 89 ± 16 5 
Finally, we have sought to inhibit the extractable 
collagenolytic activity by adding several protease 
inhibitors to the assays. Table 5 summarizes the effects of 
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proteinase inhibitors on the degradation of reconstituted 
collagen type I fibrils. The inhibitory effects were similar 
in both intestinal segments with the exception of SBTI which 
appeared to be ineffective against the activities extracted 
from colonic anastomoses. The metalloproteinase inhibitors 
ethylenediamine-tetraacetic acid (EDTA) and O-phenanthroline 
partially inhibited the collagenolytic activity in both 
ileal and colonic extracts, but only when applied in high 
concentrations. This is due to the fact that the assay 
buffer contained a relatively high level of calcium ions (50 
mM). A comparable inhibitory effect could be achieved by 
using a calcium-free assay buffer. The serine protease 
inhibitors showed none (PMSF), minor (SBTI), or moderate 
(Trasylol) inhibitory capacity. Five percent serum 
(cv2-macroglobulin) proved to be the most powerful inhibitory 
agent, reducing the degradation of the collagen substrate 
to 25% or less. The human recombinant tissue inhibitor of 
metallo-proteinases (hrTIMP) was barely effective against 
the collagenolytic activity present in the extracts of the 
rat intestinal anastomoses. 
DISCUSSION 
Appropriate healing of injured tissues involves the 
removal of damaged tissue components and the synthesis and 
deposit of new material. In studies on wound healing, 
interest is generally focused on the formation of new 
connective tissue, while the degradative processes leading 
to matrix depletion receive far less attention. Still, the 
current view holds that a certain degree of extracellular 
matrix resorption is an integral part of tissue repair [23] . 
The strength of intestinal anastomoses depends, during the 
immediate postoperative period, on the 'suture holding 
capacity' of the existing collagen fibrils [24] and 
therefore control of enzyme activities capable of degrading 
these fibrils should be of particular interest to those who 
seek ways to improve intestinal healing. 
We have shown before, using only soluble type I collagen 
as a substrate, that extractable anastomotic collagenolytic 
activity was transiently increased during the first week 
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after operation [16]. It remains possible that aspecific 
proteolytic enzymes contribute significantly to the 
degradation, measured at 37°C, of such a soluble substrate. 
Therefore, we have extended these observations with 
measurements on the degradation of fibrillar substrates. For 
practical purposes, 24-h old anastomoses were used for 
extraction. The present results confirm the existence of a 
postoperative increase in collagenolytic activity. The fact 
that this effect is also apparent with both fibrillar 
substrates indicates the involvement of true collagenolytic 
enzymes rather than non-specific proteases. Recent efforts 
to measure increased collagenase activity in 1-day-old 
colonic anastomoses failed to yield a significant difference 
between anastomotic and control tissue [25] . In these 
experiments, collagenase was measured in media from cultured 
tissue expiants. Apparently, the direct measurement of 
enzyme activity in tissue extracts, employed by us, is more 
suitable to demonstrate postoperative changes. 
It is noteworthy that only minor differences in activity 
were found between assays using soluble and fibrillar type 
I as a substrate. One would expect the soluble substrate to 
be more easily degraded. An explanation may be that the 
soluble substrate in fact contained 'diffuse fibrils'[19] 
since no attempt was made to actually prevent 
fibrillogenesis during the assay. 
Fibrillar type III collagen was also used as a substrate, 
in an attempt to obtain more specific information on the 
cellular origin of the collagenolytic activity. If 
polymorphonuclear leucocytes, known to be present in great 
numbers at the chosen time point, would be the dominant 
source of collagenolytic activity, type I collagen should 
have been degraded far more easily than type III collagen, 
since the leucocyte collagenase has a significantly 
increased substrate-specificity for type I collagen [26]. 
In fact, the assay using type I as a substrate yielded only 
marginally higher activities than the assay using type III 
as a substrate. Thus, it is unlikely that polymorphonuclear 
leucocytes are the primary source for the collagenase 
activity. Recently, Chowcat et al. [15] have shown that 
infiltrating cells in the anastomotic region were not 
immunoreactive against collagenase antibodies. Therefore, 
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the role of infiltrating neutrophils as a potential source 
of collagenolytic enzymes remains questionable. Resident 
fibroblasts could be a source of enzyme activity or 
degradation may be mediated by enzymes bound extracellularly 
to matrix constituents. Still, inflammatory cells might 
actually play an important role as suppliers of collagenase 
activators, and as regulators of TIMP activity [27] . 
Furthermore, these cells secrete cytokines: powerful 
stimulators of fibroblast cell proliferation and cellular 
production of collagenolytic enzymes. 
Loss of collagen fibrillar structures from the 
anastomotic area is expected to decrease the 'suture holding 
capacity' of the intestinal wall, increasing the risk for 
anastomotic failure. It is very interesting to observe that 
the postoperative increase in collagenolytic activity was 
significantly higher around colonic than around ileal 
anastomoses. This result supports the hypothesis that the 
immediate postoperative collagen degradation is greater in 
colon than in ileum [13] . In addition, we have found 
recently that postoperative anastomotic collagen synthesis 
is delayed in colon as compared to ileum [28]. Together, 
these phenomena may induce a state of lowered collagen 
levels in the anastomotic area which is more extensive and 
longer-lasting in colon than in ileum. This could be one of 
the reasons that chances for dehiscence are greater in 
colonic anastomoses and thus explains the higher failure 
rates of anastomoses in the large bowel. 
Chromatography of the products released from a 
reconstituted collagen type I fibrillar matrix has 
demonstrated two or more, simultaneously acting, processes. 
The first process results in the release of intact collagen 
molecules and its occurrence was demonstrated by the 
presence of abundant mono-, di- and polymeric collagen 
chains in the assay supernatants. Both ileal and colonic 
extracts solubilized intact collagen molecules while buffer 
alone did not release any collagenous material. Since 
crosslinks, which hold individual collagen molecules 
together within fibrils, are mainly found in the telopeptide 
region [29], primary désintégration of the matrix seems to 
be focused on the cleavage of these stabilizing structures. 
True mammalian collagenases have, to our knowledge, never 
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been reported to be involved in cleavages in the telopeptide 
regions. Therefore, the involvement of a telopeptidase-like 
protease or 'cross-linkase'as a destabilizing enzyme seems 
to be very likely. In recent nomenclature of connective 
tissue degrading enzymes this activity is classified as 
matrix metalloproteinase type 4 (MMP-4) [30]. 
The solubilization of intact collagen molecules is most 
likely followed by the action of a classical vertebrate 
collagenase. These enzymes are generally accepted to be, 
physiologically, the most prominent proteases capable of 
inducing a primary scission in the tight α-helix domain of 
a collagen molecule. Demonstration of the presence of the 
characteristic lysis products of this scission, 25% and 75 
% long peptides, is commonly taken as evidence for the 
presence of a true mammalian collagenase (MMP-1). The 
difficulties we encountered to identify these primary lysis 
products are most likely due to the heterogenous composition 
of the extracts. However, the results shown in Fig. 3 
clearly demonstrate the presence of a true mammalian 
collagenase in the extracts of both ileal and colonic 
anastomoses. 
Modulation of collagen breakdown around intestinal 
anastomoses should, ideally, affect the rate limiting step 
in the lysis process. Within the sequence of activities 
previously mentioned, the true mammalian collagenase 
represents an important target of for the inhibition of 
collagen degradation. The tissue inhibitor of 
metalloproteinases has been shown to be a powerful in vitro 
inhibitor of active collagenase (MMP-1) . However, inhibition 
studies carried out with human recombinant TIMP (hrTIMP) 
revealed that this inhibitor was hardly effective against 
the activity extracted from rat intestinal tissue samples. 
A possible explanation for the lack of inhibitory activity 
of hrTIMP against our extracts might be a different affinity 
of hrTIMP for the collagenolytic enzyme(s) synthesized by 
rat cells. Very recently evidence has been presented for the 
existence of a second TIMP-like inhibitor (TIMP-2) [31] and 
it has been proposes that there exists a family of 
TIMP-related (glyco-)proteins with more or less specific 
target enzymes within the family of the metalloproteinases. 
The unexpected lack of inhibitory activity of the hrTIMP 
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against the rat enzyme may be explained within this 
perspective. Another explanation might be sought in the fact 
that rat enzymes differ remarkably in their amino acid 
composition from the human analogues. Thus, it remains 
possible that hrTIMP, although not inhibitory against the 
collagenolytic activity detectable in our rat wound healing 
model, might be an important agent in preventing excessive 
collagen degradation in other species, including man. 
Further experiments are necessary to investigate this 
possibility. 
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CHAPTER 4 
COLLAGENASES FROM HUMAN AND RAT SKIN FIBROBLASTS PURIFIED 
ON A ZINC CHELATING COLUMN REVEAL MARKED DIFFERENCES IN 
LATENCY AS A RESULT OF SERUM CULTURE CONDITIONS. 
JOS W.J. VAN DER STAPPEN, THIJS HENDRIKS AND BEN M. DE MAN. 
Int. J. Biochem. Vol 24 No. 5, pp 725-735, 1992 
ABSTRACT. 
1. Fibroblasts from both human and rat skin were grown in 
the presence or absence of serum and the collagenase 
activity in the medium was partially purified on zinc-
Sepharose. 
2. During chromatography, using a discontinuous elution 
gradient, the rat collagenase elutes at different pH and 
ionic strength than the human collagenase. Both latent and 
active collagenases of both species are retarded by the 
affinity matrix. 
3. Latency of collagenase in media obtained from fibroblast 
cultures appears to be influenced by the presence of serum 
in the culture medium. 
4. The results demonstrate that collagenases secreted by 
fibroblasts cultures established from the same tissue but 
obtained from different species are biochemically diverse 
and that, within one species, the amount of active enzyme 
depends on the presence of a serum factor. 
INTRODUCTION 
Vertebrate collagenases are believed to play an important 
role in the pathogenesis of a number of connective tissue 
diseases, in metastasis and growth of tumors and in wound 
healing, (for reviews see Harris and Cartwright, 1977; 
biotta et al., 1986). Since the first isolation of a 
vertebrate collagenase from the culture medium of the 
tadpole tailfin by Gross and Lapiere (1962) this class of 
enzymes has been the subject of extensive research. Study 
of collagenases in tissue extracts appears to be hardly 
possible because of the very low concentrations found in 
vivo. Most of the work on vertebrate collagenases has been 
performed on collagenases isolated from the culture media 
of an extended number of cell types. Among the cell types 
capable of producing large amounts of collagenase, 
fibroblasts (Birkedal-Hansen et al., 1976), macrophages 
(Welgus et al., 19Θ5), keratinocytes (Lin et al., 1987), 
polymorphonuclear leucocytes (Hibbs et al., 1984) and tumor 
cells (Liotta et al., 1986) are the most well known. 
Collagenases synthesized by cultured cells are released 
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into the culture medium largely in an inactive proenzyme 
form (Bauer et al., 1975). The mechanism of conversion of 
the inactive precursor to a catalytic form still needs to 
be elucidated. Activation in vitro may be achieved either 
by proteolytic enzymes such as trypsin and plasmin or by 
exposure to organomercurials such as aminophenyl mercuric 
acetate (АРМА). Highly purified collagenases have been 
obtained from concentrated culture medium of rheumatoid 
synovial tissue (Woolley et al., 1975), human skin 
fibroblasts (Stricklin et al., 1977), and pig synovial 
tissue fibroblasts (Cawston and Tyler, 1979) using 
established chromatographic techniques. 
Wound healing in the intestine, and the essential role 
of the processes of collagen synthesis and degradation, are 
topics of current research interest in our laboratory. Since 
the animal model used in these studies is the rat, we are 
particularly interested to obtain purified collagenase from 
a rat source. In an effort to purify the collagenase 
produced by rat skin fibroblasts we observed remarkable 
differences in the behaviour of the enzyme if subjected to 
purification schemes previously described for collagenases 
from other sources. In the present study we describe the 
partial purification of two collagenases, secreted by rat 
and human skin fibroblasts, on a zinc-affinity column and 
demonstrate that the presence of serum in the culture medium 
influences the enzymatic form of the collagenase secreted. 
Abbreviations used: АРМА, aminophenyl mercuric acetate; DMEM, 
Dulbecco's modified Eagle medium; PMA, phorbol 12-myristate 13-
acetate; TIMP, tissue inhibitor of metalloproteinases; DMSO, 
dimethylsulphoxide; SDS-PAGE, sodiumdodecylsulphate 
Polyacrylamide gel electrophoresis; PMSF, phenyl-
methylsulphonylfluoride. 
MATERIALS AND METHODS 
Materials 
Chemicals were obtained from the following suppliers: 
Dulbecco's modified Eagle's medium (DMEM) and lactalbumin-
hydrolysate were obtained from Gibco Limited, Scotland; Brij 
35, phorbol 12-myristate 13-acetate (PMA) from Sigma 
Chemical Company, U.S.A.; tissue culture plastics from 
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Intermed NUNC, Denmark; penicillin from Gist-Brocades NV 
Delft, The Netherlands; streptomycin from Pharmachemie 
Haarlem, The Netherlands; [14C] acetic anhydride from The 
Radiochemical Centre, Amersham, Bucks., U.K.; Sepharose 6B 
from Pharmacia, Woerden, The Netherlands; Spectra/Por 6 
dialysis membrane from Spectrum Medical Industries, Los 
Angeles, U.S.A.; Aqua Luma from Lumac BV, Landgraaf, The 
Netherlands and the 96 wells high affinity tissue culture 
plates from Greiner, Alphen a/d Rijn, The Netherlands. The 
human recombinant tissue inhibitor of metalloproteinases 
(hrTIMP) was a gift from Dr. G. Murphy, Strangeways Research 
Laboratories, Cambridge, U.K. All other chemicals were of 
analytical grade. 
Culture conditions 
Human fibroblast cultures were initiated from punch 
biopsies of the back skin of healthy volunteers. The 
specimens were minced (2x2 mm) in sterile tissue culture 
plates and overlaid with 5 ml of DMEM, supplemented with 10% 
fetal calf serum, containing 100 I.E. penicillin and 100 
I.E. streptomycin/ml. The cell cultures were maintained in 
a humidified 5% C02, 95% air incubator at 37°C. After 
approximately 14 days, the fibroblasts were harvested from 
the primary cultures by treatment with 0.05% trypsin and 
replated. Light microscopy confirmed that fibroblasts were 
the only cell type present. Established cultures were grown 
to confluency in large 175-cm2 tissue culture flasks in 50 
ml DMEM containing 10% fetal calf serum and antibiotics and 
were refed every third or fourth day. All conditioned media 
were collected at every change (of medium) and neutralized 
by adding 5 ml of a 1.05 M Tris-HCl buffer, pH 7.6, 
containing 0.21 M CaCl2 and 1.05% Brij 35 to every 100 ml of 
culture medium. Neutralized medium was clarified by 
centrifugation at 10000 χ g for 3 0 min (4°C) and frozen at 
-30°C until further processing. Cultures reaching confluency 
were harvested and washed three times with Hanks buffer 
(without Ca and Mg) to remove all serum remnants. Washed 
cultures were put through five 24 h cycles of maintenance 
in serum-free DMEM, containing 50 ng/ml PMA and 0.2% 
lactalbumin-hydrolysate. After each 24 h cycle the culture 
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medium was harvested and replenished by fresh serum-free 
medium. Harvested serum-free medium was treated as mentioned 
above. After maintenance in serum-free medium, fibroblast 
cultures were returned to serum-supplemented medium for 
several days before being recycled for another 5 days in 
serum-free culture medium. 
Rat skin fibroblast cultures were established from the 
back skin of germ-free male Wistar rats. Culture and harvest 
conditions were identical to those described for human 
fibroblasts. 
Chromatography 
All human and rat serum-supplemented and serum-f ree media 
were thawed and pooled, yielding 4 pools of collagenase 
containing solutions. Each pool was concentrated 10- to 
40-fold in an Amicon ultrafiltration cell fitted with a PM 
10 membrane. Concentrated media were dialysed against 25 mM 
sodium borate, pH 8.0, containing 0.15 M NaCl (buffer I). 
A zinc-affinity column was prepared according to Porath et 
al. (1975). Briefly, an aqueous solution of zinc chloride 
(ZnC12, 1 mg/ml was passed through a column of chelating 
Sepharose 6B. Saturation with zinc ions was accomplished as 
soon as sodium bicarbonate precipitated with zinc ions in 
the eluate. Thirty to one hundred ml of concentrated media 
were applied to a 25 χ 1.6 cm zinc affinity column 
equilibrated before with the same buffer. This buffer was 
passed through the column until the absorbance at 2Θ0 nm 
returned to baseline. The column was further eluted in a 
stepwise manner with the following buffers: (II) 25 mM 
sodium cacodylate, pH 6.5; (III) 25 mM sodium cacodylate, 
pH 6.5, plus 0.8 M NaCl; (IV) 50 mM sodium acetate buffer, 
pH 4.7, plus 0.8 M NaCl; (V) 50 mM EDTA plus 0.5 M NaCl. All 
of the above buffers contained 0.05% Brij 3 5 and 1 mM CaCl2. 
All steps were performed at 4°C. 
Binding to gelatin-Sepharose 
Fractions, eluted from the zinc-chelating column and 
containing collagenolytic activity were pooled and analyzed 
batch-wise for their capacity to bind to gelatin. Pools 
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enriched in rat or human collagenase (see results section) 
were dialysed against 20 mM Tris-HCl, pH 7.5, containing 5 
mM CaCl2, 0.5 M NaCl and 0.05% Brij 35 (GS-buffer). One ml 
samples of the dialysed pools were added to a 100 μΐ 
gelatin-Sepharose suspension, equilibrated before with the 
same buffer, and rotated for 4 h at 4°C. Subsequently, the 
suspension was centrifugated (5 min, 500 χ g) and 1 ml 
supernatants were collected. The gel matrix was washed twice 
again with 1 ml GS-buffer and 1 ml supernatants were 
collected. Dissociation of bound material was accomplished 
by the addition of 500 μΐ 10% (v/v) dimethyl sulphoxide 
(DMSO) to the GS-buffer followed by rotation for 2 h at 4°C. 
After centrifugation 450 μΐ of the supernatant was 
collected. The DMSO wash was repeated once. All fractions 
were analyzed for collagenolytic activity using fibrillar 
type I collagen as a substrate. 
Assay of collagenolytic activity 
Collagenase activity was measured by a soluble assay 
using [14C] -labelled soluble type I collagen and two assays 
using [14C] -labelled reconstituted type I and type III 
fibrils, respectively. Type I collagen used in the soluble 
assay and type III collagen used in the fibrillar assay were 
purified from pepsin-solubilized fetal calf skin. Type I 
collagen used in the fibrillar assay was purified from the 
acid-soluble fraction of fetal calf skin. Purification of 
the collagens was achieved by differential salt 
fractionation at neutral pH (Miller and Rhodes, 1982). In 
order to obtain pure type III collagen the salt 
fractionation procedure was performed repeatedly, resulting 
in a purity of at least 95%, as determined by 
sodiumdodecylsulphate Polyacrylamide gel electrophoresis 
(SDS-PAGE; data not shown). The purified collagens were 
labelled with [1-"C]-acetic anhydride (25 mCi/mmol) 
according to Cawston and Barrett (1979). Labelled collagens 
(0.25-0.50 дСі/тІ) were dialysed exhaustively against 0.1 
M acetic acid using a 50000 D Spectrapor 6 membrane, prior 
to storage at -30°C. 
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Soluble assay 
Assays were carried out in 5-fold replicates in 1.5 ml 
microtubes : 50 μΐ of each column fraction was added to 20 
μΐ of [14C] collagen (1.25 mg/ml) and 200 μΐ 50 mM Tris-HCl 
(pH 7.8), containing 50 mM CaCl2 and 0.5 M NaCl; 50 μΐ of 
dialysis buffer was added to control tubes. The reaction was 
allowed to proceed for 4 h at 37 °C and subsequently 
terminated by the addition of 50 μΐ 50 mM Tris-HCl (pH 7.8) , 
containing 0.2 M EDTA. Since no measures were taken to 
prevent fibrillogenesis during the incubation period, the 
soluble substrate may actually have been converted into 
'diffuse fibrils' (Cawston and Barrett, 1979). After 
reincubation at 40°C for 15 min, to allow denaturation of 
the degradation products, 100 μΐ of 5 M NaCl/glacial acetic 
acid (9:1, v/v) was added and the tubes were placed on ice 
for at least 30 min (Seng et al., 1984). The tubes were 
centrifuged at 10000 χ g for 10 min and 100 μΐ of the 
supernatant was mixed with 3 ml of Aqua Luma and counted in 
a liquid scintillation analyzer. 
Fibrillar assays 
Collagen type I or III solutions in acetic acid were 
neutralized by dialysis against 30 mM Tris-HCl (pH 7.3), 
containing 30 mM Na2HP04.2H20 and 135 mM NaCl (Williams et 
al, 1978). Aliquots of 20 μΐ neutralized collagen solution 
were applied to each well of a 96 wells high affinity tissue 
culture plate and allowed to gel for 1 h in a humidified 
atmosphere at 37°C (Johnson-Wint, 1980) . After gelling the 
plates were air-dried in a laminar flow hood. Dried plates 
were washed twice with 200 μΐ of demineralized water to 
remove remnants of buffer. Plates treated this way and 
stored at 4°C did not deteriorate for at least 2 weeks. 
Assays were carried out in triplicate: 50 μΐ of the column 
fraction or appropriate column buffer (as a control sample) 
and 150 μΐ of 50 mM Tris-HCl (pH 7.8), containing 50 mM 
CaCl2 and 0.5 M NaCl were applied to each well. The reaction 
was allowed to proceed for 22 h at 37°C in a 100% humidified 
atmosphere to avoid evaporation. At the end of the 
incubation period the whole content of each well was 
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transferred into microtubes and centrifuged at 10000 χ g for 
10 min. A 100 μΐ sample from the supernatants was 
transferred into scintillation vials and mixed with 3 ml 
of Aqua Luma and counted in a liquid scintillation analyzer. 
Since organomercurial compounds are known to activate latent 
(pro)-collagenase, 1 mM АРМА (final concentration) was 
routinely added to the incubations. In order to estimate the 
amount of active collagenolytic activity in the column 
fractions assays were also carried out without АРМА. 
Specific protease inhibitors were added to the assay 
buffer in order the characterize the collagenolytic 
activity. The effects of inhibitors were determined from the 
residual activities after co-incubation of the extracts with 
the protease inhibitor. The collagenolytic activity was 
expressed as μg [14C] -labelled collagen/degraded/h under the 
conditions stated. 
SDS-PAGE 
Fibrillar type I assay supernatants obtained after 
incubation of 75 μΐ of partially purified collagenase with 
225 μΐ assay buffer and 20 μΐ [14C] -labelled collagen for 24 
h at 22°C were dialysed against demineralized water and 
lyophilized. Lyophilized material was separated by SDS-PAGE 
using 10% Polyacrylamide according to Laemmli (1970). 
Protein bands were visualized by standard autoradiography. 
RESULTS 
Conditioned culture medium, when neutralized and 
supplemented with 1 mM CaCl2 and 0.05% Brij 35 and stored at 
-30°C, retained its collagenolytic activity over a period 
of at least several months. Collagenolytic activities of 
relevant column fractions were measured in the three assays 
described above. Activity profiles were similar no matter 
what substrate or substrate form was used (Figure 1). We 
observed only minor differences in activity profiles between 
assays run with a fibrillar substrate and assays run with 
a soluble substrate. Figure 1 also shows that the soluble 
type I substrate is more readily degraded than the type I 
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Figure 1. Zinc-chelated column chromatography of conditioned 
serum-free culture medium of human skin fibroblasts. Sixty ml of 
concentrated medium was dialysed against buffer I (see Methods 
section), applied to a 16 χ 115 mm column and eluted (30 ml/hr) 
in a stepwise manner with buffers II-V. Collagenolytic 
activities in the eluate fractions (5 ml) were assayed using 
soluble type I (a), fibrillar type I (b) and fibrillar type III 
(c) collagen as a substrate. All assays represent total 
collagenolytic activity; 1 mM АРМА was included in the assay 
buffers. Absorbance (A2B0) is depicted in the upper part of the 
figure by the dotted line. 
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more easily degraded than the type I fibrillar substrate. 
Since the results obtained by the soluble assay did not 
differ significantly from those obtained by the fibrillar 
assays but yielded much higher activities, only the column 
profiles obtained with the soluble assay, in all cases 
performed both with and without АРМА, will be shown in the 
next section. 
Rat skin collagenase, in either latent or active form, 
was partially purified from fibroblast culture medium. 
Although unexpected, because of the presence of potent 
collagenase inhibitors such as ar2-macroglobulin in serum, 
media from serum-supplemented fibroblast cultures contained 
significant quantities of latent enzyme (Figure 2). 
Collagenolytic activity in serum-supplemented conditioned 
medium of rat fibroblast cultures eluted in two distinct 
peaks: the first peak eluted when the column was washed with 
buffer II (see Methods section); an additional peak eluted 
when the column was washed with the same buffer but with an 
increased ionic strength (buffer III). If АРМА was omitted 
from the collagenolytic assays it became clear that both 
collagenase containing peaks represented latent forms of the 
enzyme: residual activities measured without АРМА were about 
3% of the total enzymic activity. Eluted fractions were 
pooled (R+(A) , R+(B) and R+(C)) as indicated in Fig. 2. 
Table 1 gives the recovery and purification factors for the 
individual pools. The observed increase in total 
collagenolytic activity is possibly due to underestimation 
of the activity in the concentrated medium pool. 
Interference of medium proteins with АРМА, leading to 
insufficient activation of the enzyme in the concentrated 
pool, or removal of metalloproteinase inhibitors by the 
chromatographic procedure, may not be excluded either. 
Collagenolytic activity from the same cells, but produced 
after switching to serum-free culture conditions, also 
eluted in two separate peaks from the zinc affinity column 
(Fig. 3) . Apparently, the collagenase activity in these 
peaks was already in an active form. Since all media were 
treated identically after harvesting, it seems reasonable 
to assume that activation of the zymogen took place 
immediately after secretion. The highest collagenolytic 
activity was, unlike that in serum supplemented medium, now 
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found in the first eluted peak. Table 1 shows that a large 
percentage (73%) of the collagenolytic activity was lost 
during chromatography. Possibly, the presence of, mainly 
latent, activity in the unbound fractions contributed 
considerably to this loss. The peaks obtained after 
zinc-chelate chromatography were pooled and aliquots were 
incubated with fibrillar type I as a substrate in order to 
identify the cleavage products. Figures 4(a) and (b) (lanes 
С and D) depict the electrophoretograms of these products, 
visualized by autoradiography, from peak fractions obtained 
from serum-free and serum-supplemented media, respectively. 
Collagen degradation products specific for true mammalian 
collagenase, in particular the 75% TcA fragment, (and 25% 
TcB cleavage products) were detectable in the assay 
supernatants. Lanes С and D of Fig. 4 (a) show degradation 
products of the serum-free pools R-(A) and R-(Β), 
respectively. Lanes С and D of Fig. 4(b) show these products 
for the serum containing pools R+(A) and R+(C), 
respectively. Non-specific degradation products of 
intermediate molecular weight were not observed. 
Table 1. Partial purification of collagenase obtained from rat 
and human fibroblast culture medium. 
Source Total Total Specific Yield Purification 
collagenolytic protein activity (%) (factor) 
activity (mU) (mg) (mU/mg) 





















































































Collagenolytic activity was measured using [14C] labeled 
reconstituted type I collagen fibrils, incubated with АРМА 
activated samples for 22 h at 37°C. Source codes refer to the 













Figure L Zinc-chelated affinity chromatography of rat 
fibroblast collagenase obtained from serum-supplemented culture 
medium Sixty ml of concentrated culture medium, dialysed against 
25 mM sodium borate, pH θ.0 containing 0 15 M NaCl (Buffer I), 
was loaded onto a column (25 χ 1.6 cm) of chelating Sepharose 6B 
saturated with ZnCl2. The column was eluted in a stepwise manner 
(indicated by arrows) with the following buffers, (II) 25 mM 
sodium cacodylate, pH 6.5, (III) 25 mM sodium cacodylate, pH 6.5 
containing Ο.θ M NaCl; (IV) 50 mM sodium acetate, pH 4.7, 
containing 0 8 M NaCl; (V) 50 mM EDTA, plus 0.5 M NaCl adjusted 
to pH 7.0. All buffers contained 0.05% Bri] 35 and 1 mM CaCl2. 
The column was eluted at a flow rate of 30 ml/hr. 5 ml fractions 
were collected and assayed for collagenolytic activity using 
soluble type I collagen as a substrate (——) Total collagenase 
activity (assayed + АРМА); (- - -) active collagenase (assayed 
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Figure 3. Zinc-chelate affinity chromatography of rat fibroblast 
collagenase obtained from serum-free culture medium. See legend 
of Fig. 2 for details. 
Human fibroblasts, grown in the presence of serum, 
secreted collagenolytic activity that eluted in two distinct 
peaks from a zinc affinity column (Fig. 5). However, the 
elution profile was different from that obtained by rat 
fibroblast culture medium (cf. Fig. 2). Maximal 
collagenolytic activity was now found in the protein peak 
eluting with buffer IV; a smaller peak eluted with buffer 
III. The latter fractions appeared to be latent since 
exclusion of АРМА from the assays showed no residual 
activity. The other peak contained predominantly active 
collagenase. Collagenolytic activity synthesized by human 
fibroblast under serum-free conditions produced only one 
active peak after zinc-chromatography which eluted when the 
column was washed with the acidic buffer IV (Fig. 6). 
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Figure 4. (Opposite) Cleavage of reconstituted 14C-labeled type 
I collagen fibrils by human and rat fibroblast collagenase. 
Assays were carried out at 22°C for 24 hr as described in detail 
in the Methods section, (a) Samples were taken from pooled 
fractions after zinc affinity chromatography. Separated media 
were of serum-free origin. Lane A, type I collagen; lane B, plus 
assay buffer; lane C, plus a sample from rat pool R- (A) ; lane D, 
plus sample from rat pool R-(B); lane E, plus sample from human 
pool H- (A) and lane F, plus sample from human pool H- (B) . (b) 
Samples were taken from pooled fractions after zinc affinity 
chromatography. Separated media were of serum-supplemented 
origin. Lane A, type I collagen; lane B, plus assay buffer; lane 
C, plus a sample from rat pool R+(A); lane D, plus sample from 
rat pool R+ (C) ; lane E, plus sample from human pool H+ (A) and 
lane F, plus sample from human pool H+(B). 
The efficiency of the purification of the human 
collagenases is shown in the lower part of Table 1. Total 
collagenolytic activity exceeded in both cases the amount 
of activity measured in the original sample. An 
underestimation of the activity in the concentrated sample 
as well as the removal of TIMP by column chromatography, are 
reasonable explanations for this phenomenon. 
Collagenase containing fractions were pooled and aliquots 
were tested for their ability to degrade reconstituted 
fibrillar type I into specific cleavage fragments. Figure 
4(a) and (b) (lanes E and F) confirm that true mammalian 
collagenase was present in the human eluate pools for, 
respectively, serum-free (pool H-(B)) and serum-rich (H+(A) 
and H+(B)) culture conditions. Contrary to the findings in 
rat material, no degradation products were released by the 
buffer-Ill pool (H-(A)) of serum-free cultured human 
fibroblasts (Fig. 4(a), lane E) . However, non-collagen-
olytic, "telopeptidase-like", activity in the H-(A)pool and 
all the other pools, appears to be responsible for the 
release of intact a mono- and dimers. Incubations with 
buffer alone (lane В of Figs 4(a) and (b) ) confirm this 
interpretation since no collagenous material was detectable 
in these supernatants. 
The pooled fractions of both human and rat sources were 
incubated batch-wise with a Sepharose-4B coupled gelatin-
affinity matrix to examine if collagenase activity would 
bind to gelatin, thus indicating the capacity to also act 
as a gelatinase. This experiment shows that part of the 
collagenase pools obtained from serum-free rat culture 
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medium indeed bound to the gelatin-matrix: 30% of the R-(A) 
pool and 49% of the R-(B) pool, respectively. The latter 
activity represents, according to the specificity of the 
matrix and its property to degrade the reconstituted 
fibrillar type I substrate, very likely gelatinase or MMP-2. 
The pools of collagenolytic activity, obtained from human 
fibroblasts, cultured both in the presence and absence of 
serum, or from rat fibroblast cultured in the presence of 








Figure 5 : Zinc-chelated affinity chromatography of human 
fibroblast collagenase obtained from serum-supplemented culture 
medium. See legend of Fig. 2 for details. 
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Figure β. Zinc-chelated affinity chromatography of human 
fibroblast collagenase obtained from serum-free culture medium. 
See legend of Fig. 2 for details. 
Samples from the eight eluate pools were also incubated 
with fibrillar type I collagen at 22°C in both the presence 
and absence of АРМА and the supernatants were subjected to 
SDS-PAGE and autoradiography. Figure 7 depicts the results 
for the pools obtained from human fibroblasts. Pooled rat 
eluates showed similar results and are therefore not shown. 
The amount of degradation products of fibrillar type I 
collagen released by the action of active and stimulated 
(latent + active) eluate pools is a clear reflection of the 
ratio between active and total activity measured by the 
soluble assay. For example, the amount of collagenous 
degradation products released from a matrix of reconstituted 
type I fibrils by a sample taken form the H+(B) pool clearly 
shows the difference in activity between total (lane C) and 
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Figure 7. SDS-PAGE of products solubilized by incubation of 
reconstituted 14C-labeled collagen type I fibrils with partially 
purified human fibroblast collagenase: Influence of stimulation 
by АРМА. Lanes A, C, E and G: degradation of fibrils by 
ΑΡΜΑ-stimulated collagenase from pools H+(A), H+(B), H-(A) and 
H-(B), respectively. Lanes B, D, F and H: degradation products 
obtained after incubation with collagenase from the same pools, 
in the absence of АРМА. Protein bands were visualized by 
autoradiography. 
Table 2 . Effect of protease inhibitors on collagenolytic activity 






















































Code refers to numbered bars in Figs 2, 3, 5 and 6. Final 
concentrations of inhibitors used are TIMP: 5U/ml, EDTA: 40 mM 
and PMSF: 2 mM. Activities, measured in the presence of АРМА, are 
expressed as percentage of activity without added inhibitor. 
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active (lane D) collagenase. This relation is similar to the 
one exhibited by the corresponding peak fraction and 
measured by the biochemical assay (cf. Fig. 5). This 
observation also confirms the reliability of the soluble 
assay in the screening of the column fractions. 
Finally, the pools containing collagenolytic activity 
were assayed in the presence of some specific proteinase 
inhibitors using fibrillar type I collagen as a substrate. 
The results of these experiments are summarized in Table 
2 . No serine protease activity was detected in the fractions 
obtained after chromatography. Human recombinant TIMP, 
added to the assay buffer in the presence of АРМА, inhibited 
the rat and human enzyme pools with the exception of the 
pool obtained when human serum-free medium was processed. 
However, the latter sample was strongly inhibited by EDTA. 
EDTA markedly inhibited most partially purified samples. The 
differences in inhibitory potential, sometimes found between 
TIMP and EDTA are apparently due to different inhibitory 
mechanisms. Complete inhibition of activity could only be 
achieved by increasing EDTA concentrations (data not shown) . 
We have not investigated the effect of increasing TIMP 
concentrations because of the limited availability of this 
compound. 
DISCUSSION 
Our study unequivocally demonstrates that collagenases 
secreted by fibroblast cultures established from one tissue 
but obtained from different species are biochemically 
diverse. Furthermore, we have presented evidence that, 
within one single species, the diversity can be induced by 
the addition of serum to the culture medium. 
Fibroblasts, synthesizing true mammalian collagenases 
(MMP-1) are also capable of a simultaneous production of 
other members of the matrix metalloproteinase family (e.g. 
Murphy et al., 1987). Therefore, we have investigated the 
presence of gelatinase in the pooled collagenolytic 
fractions by measuring the binding of collagenolytic 
activity to gelatin. With the exception of the pools 
obtained from serum-free cultured rat fibroblasts, hardly 
any binding could be detected. In this case, both the bound 
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(gelatinase) and unbound (collagenase) fractions degraded 
reconstituted type I collagen fibrils. Thus, one should be 
aware that collagenase purified from rat cells may contain 
considerable gelatinase activity. 
Latent human collagenase secreted by fibroblasts cultured 
with serum appears to become more alkaline compared to the 
enzyme secreted by cells in a serum-free environment since 
in the former situation the zymogen partially elutes with 
buffer of less acidic pH. Human collagenase, both the 
zymogen and the active enzyme, obtained from serum-free 
cultures can only be removed from the column with an acidic 
buffer. A possible explanation of this phenomenon might be 
the binding of serum proteins to that part of the enzyme 
that is spliced off during proteolytic activation. Bound 
serum components might mask acidic residues in this region 
of the enzyme, thus reducing its binding to the matrix. 
The effect of serum proteins on rat collagenase is of a 
more complex order since two apparently independent effects 
can be observed. First we have seen that if serum is added 
to the culture medium only the zymogen is detectable, 
eluting in two separate fractions from the column, 
indicative for different binding forces. Secondly, we have 
found that in serum-free cultures the majority of the enzyme 
was detectable in an active form. A similar observation was 
made by Bauer et al. (1972) for the serum-free culture of 
human skin expiants. Simultaneously we observed a diminished 
affinity for the matrix of a significant quantity of the 
enzyme since elution was now largely accomplished by a 
buffer of less ionic strength. The first effect, a lack of 
activated enzyme, may be explained by an irreversible 
inhibition of the active enzyme by serum inhibitory 
components. Active enzyme, complexed by a serum inhibitor, 
might therefore escape detection by our collagenolytic 
assays. This explanation might also cover part of the second 
serum effect mentioned, namely that in the absence of serum 
two, largely active, peaks were detected. The shift towards 
less strongly bound enzyme, observed in the elution profile 
obtained after serum-free culture, may be caused by the same 
mechanism as proposed for the human enzyme: serum factors 
masking amino acid side chains, thus increasing or 
diminishing the ultimate binding of the protein to the 
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matrix. 
Next to the differences observed between active and 
latent rat and human collagenases we also demonstrated that 
species derived structural differences are apparent. 
Preliminary work on the purification of rat collagenase in 
our laboratory has demonstrated that this enzyme differs in 
molecular weight and overall charge from the human enzyme. 
Rat collagenase revealed a clearly higher molecular weight 
than the human enzyme when eluted over a G-2 00 
gel-filtration matrix. In contrast to the human enzyme which 
was not retarded by a Sephadex QAE-A50 column the rat 
enzyme strongly bound to this anion exchange matrix (van der 
Stappen: unpublished data). The inability of collagenase to 
bind to a QAE-A50 matrix was also observed by Woolley et al. 
(1975) for human rheumatoid synovial collagenase and by 
McCroskery et al. (1975) for a rabbit tumor derived 
collagenase. The human enzyme was shown to be bound by 
cation exchange matrices (Stricklin et al., 1977; Wilhelm 
et al., 1984). Roswit et al. (1983) showed a relative 
predominance of acidic amino acids in the rat uterine 
collagenase when compared to the basically charged human 
enzyme (Woolley et al., 1975) , which is consistent with the 
behavior of both molecules on ion-exchange matrices. 
The use of the zinc affinity matrix as a first 
chromatographic step in a purification procedure is probably 
a useful tool in separating the zymogen from its active 
form. Previously described purification methods using 
zinc-chelating matrices (Cawston and Tyler, 1979; Roswit et 
al., 1983; Birkedal-Hansen, 1987; Zuckeretal., 1988) never 
mentioned the possibility to discriminate between latent and 
active enzyme by using this procedure. One might easily 
overlook the application if this matrix is used further in 
the purification procedure: earlier reports have shown that 
certain chromatographic steps preceding zinc affinity 
chromatography are responsible for activation during 
purification (Tyler and Cawston, 1980; Stricklin et al., 
1983; Zucker et al., 1988). Also, the concentrated medium 
has been activated prior to any chromatographic step (Tyler 
and Cawston, 1980,- Zucker et al., 1988). Roswit et al. 
(1988), in their efforts to purify collagenase from serum 
containing conditioned medium of human smooth muscle cells, 
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also used a zinc-chelated column as a first chroraatograhic 
step. Since they eluted the collagenase with a glycine 
gradient, comparison with the present work is impossible. 
However, it is interesting that they demonstrated that the 
presence of a serum component was required for the smooth 
muscle cells to produce collagenase. 
In order to verify that true mammalian collagenases, 
whether as a zymogen or as an active enzyme, have been 
isolated, SDS gels of enzyme (АРМА activated) treated 
collagen were run to show the presence of TCA and TCB 
fragments. The chromatograms depicted (Fig. 4) confirm the 
presence of true mammalian collagenases in our preparations 
and also show that proteases, potentially interfering with 
the collagenase assays, appear to be absent since additional 
aspecif ic cleavage products were not observed. These results 
are further substantiated by the inhibitor studies. Although 
the metalloproteinase inhibitors used are not always equally 
effective, inhibition of collagenolytic activity based on 
TIMP and/or the metal-chelating properties of EDTA is 
evident. 
The present study has shown ways to obtain partially 
purified latent collagenase from both human and rat 
fibroblast cultures simply by using conditioned medium from 
serum supplemented cultures. The reasonable amounts of 
partially purified zymogen, obtained in a one step 
chromatographic procedure, may be very useful in activation 
and inhibition studies of this metalloproteinase. Activation 
of latent collagenase is hypothesized (Murphy et al., 1987; 
He et al., 1989) to be the ultimate step in a cascade of 
proteolytic events which eventually results in the 
degradation of connective tissues in normal and pathological 
conditions. Recent evidence for a protease-involved in in 
vivo activation of latent neutrophil collagenase has been 
reported by Capodici et al. (1989). 
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CHAPTER 5 
CORRELATION BETWEEN COLLAGENOLYTIC ACTIVITY AND GRADE OF 
HISTOLOGICAL DIFFERENTIATION IN COLORECTAL TUMORS. 
Jos W.J. van der Stappen, Thijs Hendriks, Theo Wobbes 
Int. J. Cancer: 45, pp 1071-1078, 1990 
SUMMARY 
Collagenolytic activity, extracted from 55 tumor and 
corresponding healthy intestinal control samples, was 
determined by three different assays using soluble type I 
and fibrillar type I and III collagen, respectively, as a 
substrate. The enzyme extracted from tumor digested 
collagen type I reconstituted fibrils and yielded the 
three-quarter segments characteristic for the action of one 
of the matrix metalloproteinases : MMP-1 or mammalian 
collagenase. Metal-chelating agents such as EDTA and 
O-phenanthrolin indeed inhibited this activity. 
Collagenolytic activities were calculated on the basis of 
wet weight, total DNA and total extracted protein. 
Correlations were sought between levels of activity and 
both clinocopathological stage (Dukes' staging) and grade 
of histological differentiation. In all the assays applied, 
significant correlations were found between grade of 
histological differentiation and collagenolytic activity 
expressed as the tumor/control ratios: poorly differentiated 
tumors exhibited a higher tumor/control ratio than 
well-differentiated tumors. Also, tumors penetrating into 
the serosa showed a higher tumor/control ratio than tumors 
invading the muscularis propria only. A relation between 
collagenolytic activity and clinicopathological stage was 
only observed if activities were calculated on a DNA basis. 
These results confirm a relation between histological 
appearance of a tumor and its enzymatic potential to degrade 
interstitial collagens. 
The abbreviations used are: SDS-PAGE: Sodium Dodecyl Sulphate-
Polyacrylamide Gel Electrophoresis АРМА: p-Aminophenylmercuric 
acetate. 
INTRODUCTION. 
The invasive and metastatic potential of tumors depends 
largely on the ability of tumor cells to rearrange and 
penetrate their connective tissue envelope. The intact 
extracellular matrix consists of an impenetrable three-
dimensional meshwork of collagen fibers, proteoglycans and 
glycoproteins. Infiltration of this barrier by tumor cells 
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can only be achieved by partial solubilization of basement 
membranes and the underlying connective tissue layers. 
Peptidases produced by tumor cells or by tumor-stimulated 
connective tissue host cells are held responsible for the 
initial step in tumor spread by degrading the extracellular 
matrix that surrounds all organs (Mullins and Rohrlich,1983 ; 
Biswas, 1982) . 
In the investigation of this process, much attention has 
been paid to the enzymes which are able to degrade the 
basement membrane which is the first barrier a proliferating 
tumor cell encounters (biotta et al, 1982) . The collagen in 
basement membranes is almost entirely type IV (Bornstein and 
Sage, 1980) . Penetration of this basement membrane by tumor 
cells is a prerequisite for metastasizing. Degradation of 
basement membrane collagen type IV by an enzyme derived from 
a metastatic murine tumor supports the hypothesis that tumor 
metastasis proceeds by destruction of extracellular matrix 
components (Liotta et ai,1979). 
biotta and co-workers (1980) have shown that highly 
metastatic tumor cells exhibit in vitro an increased 
capability for synthesizing a type-IV-collagen degrading 
neutral protease as compared with less agressive tumor 
cells. They suggested that this enzyme, identified as a 
metalloproteinase (Liotta et al, 1979), might serve as a 
marker for metastatic potential; this was confirmed by 
Turpeenniemi- Hujanen et al. (1985) and Nakajima et al. 
(1987). Inhibition of type IV collagenase also reduces 
invasion of tumor cells through reconstituted basement 
membrane in vitro (Reich et al.,1988). Indirect in vivo 
evidence for such differentiation in type IV collagenolytic 
activity can be found in a recent report by Havenith et al. 
(1988) , who observed an inverse relation between the amount 
of basement membrane type IV collagen immunoreactivity and 
clinico-pathological stage in a series of human colorectal 
tumors. 
Less attention has been paid to the tumor-induced 
degradation of the interstitial collagens type I and III in 
the underlying stroma although its role in tumor invasion 
might be of significant importance. Extracts of both animal 
and human tumors may contain large amounts of type I and 
type III collagenase (Hashimoto et al.,1973; Steven and 
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Itzhaki,1977; Biswas et al.,1978). Miller et al. (1976) 
purified a type III collagen degrading enzyme from the 
culture medium of a rabbit V2 carcinoma. Zucker and 
co-workers (1987) purified a metalloproteinase with 
activity against both type IV and type I collagen and 
gelatin from the cytosol of a highly metastatic mouse 
melanoma. Breast carcinoma cell lines secrete a collagenase 
which uses both type I and type III collagen as a substrate 
(Kao and Stern,1986). Tarin et al. (1982), using explants 
of murine mammary tumors, reported a positive correlation 
between type I collagenase and tumor spread. Cell cultures 
from metastatic brain tumors produce high levels of type I 
collagen degrading enzymes while benign meningiomas produce 
negligible levels of these enzymes. (Halaka et al.,1982) 
Much of the work reported on correlations between 
collagenolytic activity and tumor invasion or metastasis has 
been performed in vitro. Few data exist in which the 
occurrence of such correlations in vivo is confirmed, e.g. by 
comparing the collagenolytic activity in extracts from 
resected human tumors of varying clinico-pathological stage. 
For this reason, the present study was designed to determine 
whether, and to what extent, extracts of colorectal tumor 
tissue express collagenolytic potential against type I and 
type III collagen substrates and if there exists any 
relation to their clinico-pathological stage and grade of 
histological differentiation. 
MATERIALS AND METHODS 
Tissue source 
Fresh tissue was obtained from 55 patients which were 
operated upon for colorectal adenocarcinoma in the 
St.Radboud University Hospital. Representative samples were 
taken from the luminal side of the tumor and from healthy, 
tumor-free, intestine at the resection edge. The latter 
biopsies were composed of mucosa and submucosa only. 
Specimens were collected within 30 minutes after resection 
and frozen in liquid nitrogen. Clinicopathological staging 
was based on Astler-Coller's modification (1954) of Dukes' 
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classification: A, lesions limited to the mucosa; Bl, 
lesions invading into but not beyond the muscularis propria 
with negative lymph nodes; B2, lesions penetrating beyond 
the muscularis propria into serosa and pericolic fat with 
negative lymph nodes; CI, lesions invading into but not 
beyond the muscularis propria with positive lymph nodes; C2, 
lesions extending beyond the muscularis propria into serosa 
and pericolic fat with positive lymph nodes. Tumors which 
had metastasized to distant organs were categorized as stage 
D (Turnbull et al.,1967). Each tumor was also classified 
according to its histological differentiation grade : grade 
1 represents a well-differentiated, grade II a moderately-
differentiated, and grade III a poorly-differentiated tumor. 
Extraction of enzymatic activity 
Tissue extracts were prepared essentialy according to 
Wirl (1977) . Briefly, frozen tissue was pulverized in a 
Braun Microdismembrator. Approximately 100 mg of pulverized 
tissue was suspended in 2 ml of 10 mM Tris-HCl (pH 7.5), 
containing 0.4 M sucrose and 5 mM CaCl2 and rotated 
subsequently for 30 min. After centrifugation at 9000 χ g 
for 15 min, the pellet was washed twice with the same 
buffer. The resulting tissue pellet was then extracted for 
2 h with 5 M urea in 50 mM Tris-HCl (pH 7.5) , containing 0.2 
M NaCl and 5 mM CaCl2. After centrifugation at 40000 χ g for 
3 0 min the supernatant was dialysed for 16 h against the 
same buffer without urea in order to remove the urea from 
the extract. All procedures were performed at 4°C. 
Measurement of collagenolytic activity was performed on 
extracts immediately after dialysis. The extract, which 
sometimes became slightly cloudy during dialysis, was 
routinely shaken to homogeneity immediately before samples 
were taken. 
Assay of collagenolytic activity 
Collagenolytic activity in the tumor and control tissue 
extracts from each patient was determined by measuring the 
release of radioactive material from "C labelled collagen 
type I in solution and from type I and type III 
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reconstituted fibrils. Type I collagen used in the soluble 
assay and type III collagen used in the fibrillar assay 
were purified f rom pepsin- solubilized fetal calf skin. Type 
I collagen used in the fibrillar assay was purified from the 
acid-soluble fraction of fetal calf skin. 
Purification of the collagens was achieved by 
differential salt fractionation at neutral pH (Miller and 
Rhodes, 1982) . In order to obtain pure type III collagen the 
salt fractionation procedure was performed repeatedly, 
resulting in a purity of at least 95 %, as determined by 
SDS-PAGE (data not shown). 
The purified collagens were labelled with [1-14C] acetic 
anhydride (25 mCi/mmol; Amersham, UK) according to Cawston 
and Barrett (1979) . Labelled collagens (0.25-0.50 μΟί/πιΙ) 
were dialysed exhaustively against 0.1 M acetic acid using 
a 50000 D Spectra/Por 6 membrane (Spectrum Medical 
Industries, Los Angeles, USA), prior to storage at -30°C. 
Soluble assay 
Assays were carried out in five-fold in 1.5 ml microtubes 
: 50 μΐ of extract was added to 20 μΐ of [14C] collagen 
(1.25 mg/ml) and 200 μΐ 50 mM Tris-HCl (pH 7.Θ) , containing 
50 mM CaCl2 and 0.5 M NaCl ; 50 μΐ of dialysis buffer were 
added to control tubes. The reaction was allowed to proceed 
for 4 h at 3 7°C and was subsequently terminated by the 
addition of 50 μΐ 50 mM Tris-HCl (pH 7.Θ), containing 0.2 
M EDTA. After reincubation at 40°C for 15 min, to allow 
denaturation of the degradation products, 100 μΐ of 5 M 
NaCl/glacial acetic acid (9:l,v/v) was added and the tubes 
were placed on ice for at least 30 min (Seng et al,1984). 
The tubes were centrifuged at 10000 χ g for 10 min and 100 
μΐ of the supernatant was mixed with 3 ml of Aqua Luma 
(Lumac BV, Landgraaf, The Netherlands) and counted in a 
liquid scintillation analyzer. 
Fibrillar assays 
Collagen type I or III solutions in acetic acid were 
neutralized by dialysis against 30 mM Tris-HCl (pH 7.3), 
containing 30 mM Na2HP04.2H20 and 135 mM NaCl (Williams et 
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al, 1978) Aliquots of 20 μΐ neutralized collagen solution 
were applied to each well of a 96 wells plastic tissue 
culture plate (Greiner High Affinity plates ; Greiner, 
Alphen a/d Rijn, The Netherlands) and allowed to gel for 1 
h in a humidified atmosphere at 37°C (Johnson-Wint,1980). 
After gelling the plates were air-dried in a laminar flow 
hood. Dried plates were washed twice with 200 μΐ of 
demineralized water to remove remnants of buffer. Plates 
treated this way and stored at 4°C did not deteriorate for 
at least 2 weeks. 
Assays were carried out in triplicate: 50 μΐ of extract 
or dialysis buffer (as a control sample) and 150 μΐ of 50 
mM Tris-HCl (pH 7.8) .containing 50 mM CaCl2 and 0.5 M NaCl 
were applied to each well. The reaction was allowed to 
proceed for 22 h at 37°C in a 100 % humidified atmosphere 
to avoid evaporation. At the end of the incubation period 
the whole content of each well was transferred into 
microtubes and centrifuged at 10000 χ g for 10 min. A 100 
μΐ sample from the supernatants was transferred into 
scintillation vials and mixed with 3 ml of Aqua Luma and 
counted in a liquid scintillation analyzer. Since 
organomercurial compounds are known to activate latent 
(pro)-collagenase (Sellers et al,1977), 1 mM АРМА (final 
concentration) was routinely added to the incubations. In 
order to estimate the amount of active collagenolytic 
activity, a number of extracts was assayed both in the 
presence and in the absence of АРМА. 
Specific protease inhibitors were added to the assay 
buffer in order to characterize the possible nature and 
source of the collagenolytic activity. The effects of 
inhibitors were determined from the residual activities 
after со-incubation of the extracts with the protease 
inhibitor. 
After subtracting the blank, which routinely constituted 
less than 6% of total counts present (also in the soluble 
assay), the collagenolytic activity was expressed as ng 
[14C]-labelled collagen degraded/h/mg original wet weight, 
as ng [14C]-collagen degraded/h/g protein extracted and as 
ng [14] C-collagen degraded /h/ßg DNA. 
DMA and protein determination 
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DNA was measured by the method of Burton (1956); 1-3 mg 
(wet weight) of pulverized tissue was examined. The protein 
concentration in a 100 μΐ sample of the extract was measured 
by the method of Lowry et al (1951) , using bovine serum 
albumin as a standard. 
SDS-PAGE and autoradiography 
Reaction products of tumor and control extracts in a 
fibril type I assay (run for 24 hr at reduced temperature 
(22°C) to avoid further degradation of the TcA fragments by 
non specific proteases in the crude extracts) were pooled, 
dialysed against demineralized water, freeze-dried and 
applied to an 8% Polyacrylamide gel. Specific collagenase 
degradation products (Τ,Λ fragments) were visualized by 
electrophoresis followed by autoradiography using standard 
procedures. Rainbow protein molecular weight markers 
( [14C] -labelled) were from Amersham. 
RESULTS 
The average age of the patients in this study was 65 
years (SD : 12.5, range 26-85 years). Clinico-pathological 
stage and grade of histological differentiation of the 
tumors involved are summarized in Table 1. 
Table 1; Clinico-pathological stage and grade of histological 
differentiation of the tumor. 
Histological grading 
Dukes' 
stage I I-II II II-III III Total 
1 - - 1 
2 5 - - 8 
5 12 2 1 23 
1 2 - - 3 
1 2 2 - 7 
1 9 2 1 13 
1 
10 31 6 2 56 


















and fell within the Dukes' stage В group. Although Dukes' 
stage and differentiation grade are both important in 
predicting survival, an advanced stage did not always 
correspond with poorly differentiated tissue. The tumors 
were located in caecum (n=6), colon (n=17), sigmoid (n=21) 
and rectum (n=ll), respectively. The average collagenolytic 
activities measured in tumor and normal tissue are given in 
Table 2. 
Table 2 ; Average collagenolytic activities in extracts from 
tumor and healthy intestinal tissue. 
Collagenolytic activity 
(ng/h/mg wet weight) Tumor Control 
Type I (soluble) 
Type I (fibril) 
Type III (fibril) 
DNA ^g/mg wet weight) 
Protein (ug/ml extract) 
506 ± 446 
(66-2286) 
304 + 118 
(76-541) 
140 ± 56 
(56-257) 
8.7 + 2.8 
(3.9-19.3) 
619 + 214 
(196-1085) 
171 + 81 
(48-421) 
172 ± 74 
(46-354) 
76 ± 30 
(29-158) 
5.2 ± 1.9 
(2.0-11.3) 
353 + 160 
(11-684) 
Results are given with SD and (in parentheses) range of 
observations. Three assays for collagenolytic activity have been 
employed using soluble type I and fibrillar type I and type III 
collagen as a substrate. 
The urea-mediated extraction from both tumor tissue and 
healthy intestine yielded detectable activities in all 
biopsies for the three assays employed. In the presence of 
АРМА, degradation of reconstituted fibrillar type I collagen 
reached a maximum of 541 ng/h/mg wet weight in the tumor 
extracts and a maximum of 354 ng/h/mg wet weight in the 
extracts from healthy tissue. The only benign specimen 
excised (ID 41) showed activities in the lower range : 108 
ng/h/mg wet weight and 102 ng/h/mg wet weight, 
respectively, for the polypoid and corresponding healthy 
tissue. 
Degradation levels measured by the soluble type I assay 
were similar, certainly in the normal (sub)mucosa. However, 
119 
in tumors some very high activities were observed. The 
activities measured by the fibrillar type III assay were 
lower than those observed using type I as a substrate, but 
still detectable in all cases. 
d e g r 
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Figure 1; Collagenolytic activity measured in extracts from tumor 
and healthy intestine. Collagenolytic activity was measured using 
soluble type I (A), fibril type I (B), and fibril type III (C) 
collagen as a substrate : 0 tumor ; 0 healthy intestine. Data are 
given for each patient. average value calculated from 
tumor extracts, - - - - average value calculated from extracts 
from healthy intestine. 
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The collagenolytic activities were significantly higher 
in the tumor extracts than in the extracts from control 
specimen, if they were expressed on the basis of wet weight 
: ρ < 0.001 (Signed rank test) for all the 3 assays. 
However, the differences remained non-significant if 
activities were expressed per μg DNA or protein. Figure 1 
depicts the collagenolytic activities, expressed on the 
basis of wet weight, in both tumor and control specimen from 
all the patients; 54 out of 55 patients showed a higher 
activity in the tumor extracts, as measured with the soluble 
type I assay (Fig 1A) . If measured by the fibril type I 
assay 52 out of 55 showed a higher activity in the tumor 
(Fig IB) ; in the fibril type III assay 51 out of 52 
patients showed a higher activity in the tumor. 
Subsequently, we calculated for each patient the 
tumor/control ratio for the collagenolytic activities, as 
measured with the 3 different substrates and expressed on 
the basis of wet weight, protein and DNA. The tumor/control 
ratios were grouped according to the clinicopathological 
stage or grade of histological differentiation. This way, 
significant correlations 
Table 3 ; Correlation between grade of histological 
differentiation and tumor/control ratio for collagenolytic 
activities, expressed on the basis of wet weight. 
Tumor/control ratio 
Grade of 
histological Soluble Fibril Fibril 
differentiation (n) Type I type I type III 
I 6 2.0 ± 1.0 1.7±0.4 1 1 . 5 ± 0 . 3 
I-II 10 2.4±2.0 1.8±0.7 1 . 6 ± 0 . 5 1 
II 31 3.2±2.2 1 1.9 + 0.6 2 . 0 ± 0 . 6 1 
II-III 6 6.0 ± 4.4 2.1 + 0.5 2.1 ± 0.5 
II 2 5.5±3.3 3.2 ± 1.3 2.2 1 
Spearman correlation 
coefficient 0.419 (54) 0.237 (54) 0.3Θ1 (52) 
p-value 0.0016 0.0845 0.0054 
Activities were measured in tumor and corresponding healthy 
intestine, using one of three substrates, and expressed on a wet 
weight basis. Subsequently the tumor/healthy intestine (control) 
ratios were calculated, the tumors were grouped according to 
grade of histological differentiation and the Spearman 
correlation was calculated. Results are given as average ± S.D. 
1
 One value from this group missing: average of n-1 measurements. 
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Table 4 ; Correlation between grade of histological 
differentiation and tumor/ control ratio for collagenolytic 




















0.8 ± 0.3 
1.2 ± 1.0 
1.9 ± 1. 41 
4.0 ± 3.9 





0.8 ± 0.41 
0.9 ± 0.4 
1.2 ± 0.7 
1.4 ± 0.6 





0.7 ± 0.4 
0.8 ± 2.31 
1.3 ± 0.81 




Activities were measured in tumor and corresponding healthy 
intestine, using one of three substrates, and expressed on a 
protein basis. Subsequently the tumor/healthy intestine (control) 
ratios were calculated, the tumors were grouped according to 
grade of histological differentiation and the Spearman 
correlation was calculated. Results are given as average ± S.D. 
1
 One value from this group missing: average of n-1 measurements. 
Table 5 : Correlation between grade of histological 
differentiation and tumor/control ratio for collagenolytic 





Soluble Fibril Fibril 






















.2 ± 0.5 
.2 + 1.1 
.0 + 1.4 
.1 ± 0.9 
.9 ± 1.0 
.447 (46) 
.0019 
1.1 ± 0.3 
0.8 ± 0.3 
1.2 + 0.5 
1.6 ± 0.6 
1.1 ± 0.4 
0.288 (46) 
0.0520 
1.0 ± 0.3 
0.8 ± 2.91 
1.2 ± 0.51 




Activities were measured in tumor and corresponding healthy 
intestine, using one of three substrates, and expressed on a DNA 
basis. Subsequently the tumor/healthy intestine (control) ratios 
were calculated, the tumors were grouped according to grade of 
histological differentiation and the Spearman correlation was 
calculated. Results are given as average ± S.D. 1 One value from 
this group missing: average of n-1 measurements. 
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were found between tumor/control ratio and grade of 
histological differentiation. Tables 3,4 and 5 show the 
average tumor/control ratios for patients grouped according 
to grade of histological differentiation of the tumor, as 
calculated from activities expressed on the basis of wet 
weight, protein and DNA, respectively. With the exception 
of the tumor/control ratio calculated from the results from 
the fibrillar type I assay, and expressed on a wet weight 
basis (Table 3), strong correlations were found between 
histological differentiation and tumor/ control ratio. That 
is, the increase in tumor collagenolytic activity with 
respect to healthy intestine, rises as the tumor becomes 
less differentiated. This correlation was most significant 
if collagenolytic activities were used, which had been 
expressed on a protein basis (Table 4) . Also, the increase 
in tumor/control ratio from grade I to grade III was most 
explicit if collagenolytic activities were measured using 
soluble type I collagen as a substrate. 
If the results were grouped according to clinico-
pathological stage, no such clear correlations were 
observed. Only if tumor/control ratios were calculated from 
activities expressed on a DNA basis, and using fibrillar 
substrates, a significant (p<0.01) correlation was found: 
the tumor/control ratio increased from stage A to D. We also 
compared the tumor/control ratio in tumors which had invaded 
only the muscularis propria (essentially those classified 
Bl and CI) with that in tumors which had invaded beyond the 
muscularis and into the serosa (B2, C2 and some with 
classification D) . No differences were observed if the 
tumor/ control ratio was calculated from activities 
expressed on the basis of protein. However, if tumor/control 
ratio's were calculated from activities, expressed on the 
basis of either wet weight or DNA, significant differences 
were found from the assays using soluble type I and 
fibrillar type I collagen substrates (Table 6) . Here, tumors 
which had penetrated further into the intestinal wall, 
showed a larger increase in collagenolytic activity. This 
difference remained non-significant for the assays using 
fibrillar type III collagen as a substrate (results not 
shown). 
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Table 6; Tumor/control ratio in relation to degree of tumor 
invasion. 







2.0 ± 0.9 
(11) 




1.2 ± 0.8 
(8) 




1.4 ± 0.5 
(11) 




0.9 + 0.5 
(8) 
1.2 ± 0.5 
(28) 
0.027 
Collagenolytic activities were measured in tumor and 
corresponding healthy intestine, using either soluble or 
fibrillar type I collagen as a substrate and expressed on the 
basis of both wet weight and DNA. Subsequently, the tumor/healthy 
intestine (control) ratios were calculated for the tumors 
penetrating only the muscularis and those invading also into the 
serosa. Results are given as average ± SD. -1 Significance for 
difference between both groups was calculated using an 1-sided 
Kruskal-Wallis test. 
The effect of АРМА on the collagenolytic activity in 
tumor and control extracts was investigated in the fibrillar 
type I collagenolytic assay. Table 7 shows that the 
presence of АРМА made no difference on the level of 
collagenolytic activity, neither in tumor extracts nor in 
healthy intestine. Inhibition studies revealed that 
inhibitors specific for metalloproteinases such as EDTA (40 
mM) and O-phenanthroline (2 mM) indeed exhibited inhibitory 
activity against the collagenolytic activity in the tumor 
extracts: inhibition by 47 % and 25 % respectively was 
"found. 
Finally, the products of the degradation of fibrillar 
type I collagen by tumor extracts and extracts from healthy 
tissue were visualized after SDS-PAGE and autoradiography 
(Figure 2) . Incubation of the substrate with buffer (lane 
g) showed no solubilization of collagen chains. However, 
extracts from both healthy intestine and tumor brought 
intact α-I and a-2 monomers into solution. Tumor extracts 
appeared to degrade the monomers further in a fashion 
specific for a true mammalian collagenase, as indicated by 
the presence of 3/4 lenght TCA fragments. Using this type of 
gels (8% Polyacrylamide) , the smaller 1/4 lenght TCB 
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f ragments m i g r a t e i n t h e v i c i n i t y of t h e dye f r o n t and a r e 
t h e r e f o r e n o t i d e n t i f i a b l e . 
Table 7: Effect of АРМА (1 mM f i n a l concentrat ion) on 
c o l l a g e n o l y t i c a c t i v i t y using f i b r i l l a r type I col lagen as 
s u b s t r a t e . 
- АРМА + АРМА 
Tumor 
Healthy intestine 
64 + 22 
(18) 
36 + 9 
(19) 
67 + 19 
(19) 
33 ± 12 
(19) 
Extracts were assayed both with and without АРМА and average 
values are given (ng collagen/h/mg wet weight) with S.D. and 
number of determinations. 














Figure 2; Autoradiography of the cleavage products, separated by 
SDS-PAGE, from type I fibrillar collagen incubated with extracts 
from tumor and healthy intestine. Lane a: 14C-labelled type I 
collagen ; b: molecular weight markers ; с and e : cleavage 
products solubilized by two different tumor extracts ; d and 
f : cleavage products solubilized by extracts from the 
corresponding healthy intestine ; g: dialysed extraction buffer. 
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DISCUSSION 
Three types of assays to detect collagenolytic activity 
have been applied in this study in order to measure the 
collagen degradative potential in extracts from tumor and 
healthy intestine. We have used both soluble type I collagen 
and reconstituted type I collagen fibrils as a substrate 
because both forms might actually be present in vivo. 
Purported mechanisms of collagen degradation not only 
include a direct attack on the collagen fibrils by true 
collagenases but suppose that the initial step might also 
consist of the action of broad spectrum proteases on the 
non-helical terminal regions of the collagen molecule 
(Burleigh, 1977; Birkedal-Hansen, 1987). The latter 
proteolytic action might solubilize collagen molecules in 
a way comparable to the action of pepsin in an acidic 
environment. For instance, Etherington (1976) has reported 
the release of alpha chains from insoluble collagen by 
collagenolytic cathepsin and cathepsin Bl as a result of 
cleavage of the telopeptide region of the native collagen 
subunits. Assays performed at physiological temperatures and 
using soluble collagen substrate are not specific for true 
mammalian collagenases since non-collagenases are capable 
of degrading the helical portion of the molecule under these 
conditions (Birkedal-Hansen, 1987). 
Whenever tissue turnover rates are significantly 
increased (e.g. in wound healing and tumor growth), the 
newly synthesized connective tissue contains relatively more 
type III collagen (El-Torky et al., 1985). Since type III 
collagen appears to be a structural component of the 
intestinal wall (Graham et al., 1988) we have also measured 
the degradation of reconstituted fibril type III substrates. 
Moreover, differences in degradation rates of type I and 
type III fibrillar substrates might be helpful in the 
determination of the origin of the enzyme activity. 
Collagenase originating from polymorphonuclear leucocytes 
appears to degrade type I collagen more readily than type 
III collagen (Horwitz et al., 1977) while collagenases from 
other sources (macrophages, fibroblasts) cleave type III 
much more easily than type I (Wilhelm et al., 1984; Welgus 
et al., 1985) . 
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The extraction procedure described yielded extracts in 
which in all cases, using either of the three substrates, 
measurable collagenolytic activities could be found. This 
confirms the efficacy of the method, adopted from Wirl 
(1977), for investigations on human intestinal tissue. 
Earlier, we applied this extraction procedure to rat 
intestine (Van der Stappen et al.,1989). 
Little is known about collagenolytic activity in human 
colorectal tumors. After Dresden et al. (1972) reported that 
66% of colonic adenocarcinomas produced collagenolytic 
enzymes in organ culture, short reports claimed both a 
decreased (Sturzaker and Hawley, 1974) and an increased 
(Horowitz et al., 1987) collagenase activity in mucosal 
expiants of colon carcinomas, as compared with expiants of 
normal intestine. So far, the only more comprehensive study 
is that reported by Irimura et al. (1987) , who investigated 
type I and type IV collagenolytic activity in both extracts 
and expiant media from colorectal carcinomas. They found no 
difference in activity between tumor and normal mucosa, 
while our data show, almost without exception (Figure 1), 
an elevated enzyme activity in tumor extracts. Next to 
possible differences in biopsy composition, a difference in 
extraction procedure might be a factor of importance in 
explaining this discrepancy. Using similar enzyme assays, 
employing fibrillar type I collagen as a substrate, the 
average activity in extracts from control specimen was 14 
ng/h/mg wet weight in their series against 172 ng/h/mg wet 
weight in our material. Thus, the extraction procedure used 
by us appears to be more efficient. 
In addition to the existence of increased collagenolytic 
capacity in tumors, we have been able to demonstrate a 
strong correlation between grade of histological 
differentiation and the collagenolytic activity expressed 
as the tumor/control ratio. Such a correlation has not been 
found before. Durdey et al. (1985), studying the occurrence 
in human colorectal carcinomas of a group of peptidases 
potentially involved in collagen degradation, showed 
significantly elevated peptidase activity in tumor 
homogenates as compared with homogenates of normal colonic 
wall; no correlation was found between peptidase activity 
and either the grade of histological differentiation or 
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clinico-pathological stage of the tumor. Also, organ 
cultures of human breast neoplasms produce type I 
collagenolytic activity. Again, no correlation existed 
between collagenase secretion and histological type 
(Ogilvie et al.,1985). 
Kubochi et al. (1986) studied type I and type IV 
collagenolytic activity in homogenates of lung and gastric 
tumors in relation to histology and clinico-pathological 
staging. Their observations appear to support the developing 
notion that in tumors there exists a clear separation 
between collagenolytic activities against type IV collagen 
and type I/III collagen. The first activity is necessary 
for metastasis, while the latter activity is considered to 
be essential to local invasion. This is also supported by 
our finding that tumors which had penetrated into the serosa 
showed a higher increase in collagenolytic activity (towards 
type I collagen substrates) than tumors which had invaded 
only the muscularis propria (Table 6) . The relative lack of 
correlation in our study between collagenolytic activity and 
clinico-pathological stage of the tumor is less surprising. 
An extension of the present study with the measurement 
of type IV collagenolytic activity in colorectal tumor 
extracts might confirm the results of Havenith et al., 
(1988), who showed a significant relation between Dukes' 
staging and the amount of collagen type IV present in the 
basement membranes of colorectal tumors, although, Irimura 
et al. (1987) could not establish such a correlation. 
As in almost all studies preceding ours, the cellular 
origin of the collagenolytic activity in the tumor tissue 
can not yet be identified conclusively. Since we have 
observed only twice as much activity in the type I fibrillar 
assay compared to the type III assay, the activity does not 
appear to originate solely from either polymorphonuclear 
leucocytes or other inflammatory cells: if this were to be 
the case, a much higher difference in activity against type 
I and type III might be expected (Horwitz et al., 1977; 
Wilhelm et al., 1984; Welgus et al., 1985). The methodology 
used in this investigation does not allow us to attribute 
the source of enzyme activity either to the tumor cells or 
to the stromal elements since whole tumor segments 
presumably containing both cells and stromal elements were 
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extracted as such. 
Immune-localization studies using antibodies against type 
IV and/or type I collagenase have reported immunological 
staining to be present intracellularly (Barsky et al., 
1983), in the extracellular space (Huang et al., 1986) and 
on the surface of cultured tumour cells (Zucker et al., 
1987) . These contrasting reports clearly indicate that 
different tumors may exhibit tissue specific actions against 
host tissues and that it is of great importance to study 
tumoral actions in their natural environment. Many 
investigations have been reported on isolated tumor cells 
maintained in culture systems and thus ignoring the 
interactions between host and tumor cells. Collagenolytic 
activity released by tumor cells or by tumor induced host 
cells might be the result of a cascade of proteinolytic 
activities finally leading to the activation of latent 
mammalian collagenase (Murphy et al., 1987; He et al., 
1989). Since the proteinase cascade theory appears a very 
acceptable explanation of in vivo collagenase activation, 
further research should also include measurements of the 
enzymes potentially involved. 
The results from the inhibitor experiments indicate that 
the extracted enzymes might belong to the group of the 
metalloproteinases. This conclusion is further supported by 
our electrophoretic findings, showing the presence of 
specific collagen degradation products attributed to the 
action of MMP-1 (mammalian collagenase). Although we use 
crude extracts of intestinal tissue specimen and the 
presence of contaminating proteases is to be expected, the 
electrophoretic pattern clearly proves that classical 
mammalian collagenases are indeed involved in collagen 
degradation. The increased collagenolytic activity in the 
tumor extracts as compared to the control extracts and 
measured by the enzymatic assays are translated into 
distinct T.JV fragments on the autoradiogram from tumor 
supernatants. Cleavage fragments produced by control 
supernatants are hardly discernible. The autoradiogram 
further shows that non-specific protease activity might be 
held responsible for the release of intact collagen 
molecules from the reconstituted fibrillar meshwork. This 
"telopeptidase" activity seems to be present in equal 
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amounts in both tumor and control extracts since raonomeric 
and dimeric collagen chains are found in both supernatants, 
but not in the assay supernatants of a control sample 
containing buffer only. These results confirm the hypothesis 
of Burleigh (1977) regarding the role of broad spectrum 
proteases in the initial attack of collagenous interstitial 
structures and support the two-stage mechanism of 
collagenolysis proposed by this author. 
Our findings that all extracted collagenolytic activity 
was in an active form is in agreement with earlier data on 
tumoral collagenolytic enzymes (Hashimoto et al., 1973; 
Yamanishi et al., 1972). However, Steven and Itzhaki (1977) 
extracted a latent enzyme from rabbit tumor. These 
observations suggests that different cells secrete different 
forms of collagenase or that the activation of collagenase 
is controlled by different inhibitor levels or proteolytic 
activation. 
It is generally accepted that abnormalities of the 
colonic wall, as observed in colitis ulcerosa, and the 
presence of polyps are often the benign precursors of 
malignant colorectal tumors. Malignancy might become 
manifest over periods of more than ten years after the first 
appearance of abnormality. If were able to predict 
transformation from, for instance, a polyp to a tumor, this 
might warrant surgical intervention at an early stage and 
thus improve patient survival chances. Since collagenolytic 
activity can be measured in as little as 100 mg of wet 
weight, it would be possible to perform collagenolytic 
assays on extracts from benign polyps or biopsies of 
inflamed colonic wall. Increased collagenolytic activity in 
extracts of apparently benign tissues could then be used as 
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SUMMARY 
SUMMARY 
An important aspect of a general surgeons daily duties 
is the performance of gastrointestinal surgery. Surgical 
treatment of the gut comprises both the removal of diseased 
tissue and the subsequent restoration of the continuity. To 
achieve this the surgeon will, in almost all cases, have to 
construct an end-to-end anastomosis. An important number of 
gastrointestinal operations involves the resection of 
tumors. Since most tumors are confined to the more distal 
areas of the gut suturing will be primarily in the colon and 
in the rectum. 
Despite significantly improved surgical techniques and 
materials colorectal surgery is still attended by a 
relatively high incidence of complications due to 
anastomotic leakage. Since large numbers of microorganisms 
reside in colon and rectum leakage of colorectal anastomoses 
easily results in local or, in a more severe case, 
widespread bacterial infection. The fight against these 
complications requires not only a prolonged hospital 
admission but frequently takes a fatal ending. Surprisingly, 
the occurrence of anastomotic leakage following small bowel 
surgery is a rare phenomenon. 
In order to find ways to prevent anastomotic leakage a 
sound understanding of the biological processes underlying 
wound healing in the gut is of paramount importance. An 
important factor in the healing process that will restore 
damaged tissues is the biosynthesis of the protein collagen. 
Collagens define to a large extent the structural integrity 
of organs and tissues and are found in high concentrations 
in e.g. bones, tendons, skin and ligaments. Similarly, the 
strength of the intestinal wall is highly dependent on 
collagen, which has been deposited in its connective tissue 
layer, the submucosa. A number of studies has shown that 
collagen concentrations around an anastomosis decrease 
notably during the first postoperative period. The loss of 
anastomotic collagen is hypothesized to be caused by 
proteolytic enzymes involved in the digestion of damaged 
tissue during the early phases of wound healing. The 
strength of the anastomosis during this period is 
principally dependent on the suture holding capacity of the 
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undamaged connective tissue (i.e. collagen). The next phase 
in the healing process is characterized by an increased 
synthesis of new collagen in the injured area and will 
eventually restore pre-operative bowel wall strength. 
If the healing process deviates from its normal patterns 
as depicted above, e.g. as the result of extended 
proteolytic degradation, the regain of bowel wall strength 
will be seriously delayed and obviously the risk of leakage 
will increase. The most important enzyme responsible for the 
degradation of interstitial collagen is mammalian 
collagenase type 1 (MMP-1: matrix metalloproteinase 1) . This 
enzyme is capable of cleaving peptide bonds within the 
collagen helix, which is comprised of three polypeptide 
chains. Under physiological conditions the three peptide 
chains will uncoil and reveal further cleavage sites to less 
specific enzymes allowing the completion of collagen 
breakdown. 
Small and large bowel anastomoses exhibit greatly 
different, clinically manifest, leakage rates. Therefore, 
a comparison of the healing process in both parts of the gut 
might reveal mechanistic differences and thus indicate ways 
to lower the relatively high incidence of anastomotic 
leakage in the large bowel. 
This thesis describes the enzyme-mediated degradation of 
collagen in experimentally constructed colonic and ileal 
anastomoses in a rat model. The use of animal models always 
incorporates a certain risk that animal derived observations 
can not simply be translated to the human situation. 
Therefore, we have biochemically compared the collagenases 
from rat and human sources to expose potential species 
differences. The human derived enzyme was also studied in 
a number of tumor biopsies. 
Chapter 1 reviews the literature on wound healing in 
general and more specifically on the healing of bowel 
anastomoses. The close biological relation between the 
processes that underlie both wound healing and tumor 
invasion and metastasis is also explained here. The chapter 
continues with a comprehensive overview of the structural 
protein collagen. An understanding of the biosynthesis, 
molecular structure and the intra- and extracellular 
degradation of this protein is elemental for scientists 
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studying wound healing and the tumor associated processes 
of invasion and metastasis. 
Chapter 2 describes the development of a series of 
techniques required to start the project. Attention is paid 
to the development of an urea-based extraction procedure for 
collagenolytic activity from pre- and post-operative bowel 
segments and the evaluation of referent values such as total 
protein and DNA in the extracts. Enzymic activities were 
measured in simultaneously-constructed ileal and colonic 
anastomoses. 
The collagenolytic activity extracted from the anastomotic 
segments was significantly (even up to 4 times the control 
values in the colon) increased in both ileal and colonic 
tissues 12 hours after operation. Increased levels of 
collagenolytic activity, although gradually decreasing to 
control values, were present for up to 4 weeks post-
operatively. Return to original levels was delayed in colon 
compared to ileum. These results show that the transient 
decline in collagen concentration immediately after surgery, 
correlates with a temporary increase in collagenolytic 
activity. 
In chapter 3 we have tried to specify the increase in 
anastomotic collagenolytic activity as observed one day 
after operation. The increase was significantly more 
pronounced in large bowel than in small bowel. The use of 
reconstituted fibrillar collagen type I and III substrates 
and endopeptidase specific enzyme inhibitors allowed us to 
discuss the potential contribution of mammalian collagenase 
to the healing process in more detail. The presence of 
unique MMP-1 collagen type I cleavage products (the so 
called TcA and TcB fragments) provided the conclusive 
evidence for the presence of this enzyme. However, the 
presence and activity of other enzymes in the extracts was 
indisputable. The difference in the degradation of type I 
and type III collagen implicated a minor role for the 
collagenases derived from inflammatory cells. We postulate 
that an immobilized, inactive, store of collagenases and 
related enzymes is continuously present on extracellular 
matrix components. Upon demand, a swift conversion of these 
precursors into mature enzymes could be achieved and if 
necessary be supplemented with newly synthesized material 
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from local fibroblasts and smooth muscle cells. Inflammatory 
cells may trigger the activation of the extracellular 
proteinase reserve. Furthermore, these cells are important 
to wound healing as they release substantial amounts of 
chemotactic and growth promoting signals. 
The results of our healing studies in the rat would 
become more impressive if it could be shown that the rat 
enzyme has some analogy with the human equivalent. 
Additionally, the availability of highly purified enzyme 
preparations from rat and human origin would allow the 
production of specific antibodies. Antibodies against the 
enzymes would then enable us to perform immunolocalization 
and enzyme inhibition studies. Unfortunately, at the time 
this project was in progress, no commercial enzyme 
preparations were available and so we were forced to try to 
the purify these enzymes ourselves. In chapter 4, we 
describe how the cultures of human and rat skin fibroblasts 
provided us with crude enzyme pools. Culture medium, both 
with and without serum complement, was partially purified 
over a zinc-chelating matrix using a previously tested 
protocol. We learned that the rat and human enzyme had very 
different affinities for the matrix and that latent and 
active enzyme eluted separately from the column. Latency of 
the enzymes was dependent on the presence of serum 
complement in the culture medium. The partially purified rat 
and human enzyme preparations exhibited very little 
differences in their capability to degrade fibrillar 
collagen type I. We concluded that despite the clear 
differences in molecular structure between the human and rat 
collagenases, no outspoken differences existed that would 
invalidate our wound healing conclusions. 
There is ample evidence that the biological processes 
that determine the outcome of wound healing are equally 
important in the development of tumors. Proteolytic enzymes 
are key factors in the many physiological and pathological 
events that take place in a living organism. However, 
significant differences are found at the level of control 
of the actual process. A decline in, or occasionally the 
total lack of control of, regulatory factors can easily 
develop into a pathological condition. Chapter 5 describes 
how collagenolytic enzymes could assist in the spread and 
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local invasion often observed from tumor cells. Our study 
aimed to reveal the capacity of extracted colorectal tissues 
to degrade the interstitial collagen types I and III which, 
if in effect, would facilitate local invasion. Already, 
other investigators had shown that enzymes related to 
collagenase, the gelatinases A and B, were capable of 
degrading basement membrane type IV collagen and thus 
allowed the spreading of disseminated cells via the 
circulation. 
The collagenolytic activity was determined in 55 urea-
extracted human colorectal cancers. This activity was 
compared to the activity found in extracts obtained from 
disease-free tissue resected at some distance from the tumor 
(usually at the proximal or distal resection edge). The 
enzyme data were related to the clinico-pathological stage 
of the tumor (according to the Astler-Coller modification 
of the Dukes' staging) and the extent of tissue 
differentiation. A significant correlation existed between 
the levels of activity and grade of differentiation with 
higher collagenase activities in less well differentiated 
tumor biopsies. Patients having a bad prognosis based on the 
Dukes' staging, i.e. patients with tumors that have invaded 
the outer layers of the colon wall, contained significantly 
higher enzyme levels compared to patients with a better 
prognosis. These results provide further evidence for the 
hypothesized role of proteolytic enzymes, particularly 
enzymes involved in the degradation of interstitial 
collagens, in tumor invasion and metastasis. 
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SAMENVATTING 
Een belangrijk onderdeel van de werkzaamheden van de 
algemeen chirurg bestaat uit operaties aan het maag-
darmkanaal. Chirurgisch ingrijpen aan het maag-darmstelsel 
heeft tot gevolg dat, na het verwijderen van de door ziekte 
aangetaste delen, de continuïteit in dit orgaan moet worden 
hersteld. Om dit te bereiken zal in bijna alle gevallen een 
darmnaad (anastomose) moeten worden aangelegd. Een 
belangrijk aantal darmoperaties heeft de verwijdering van 
tumoren als doel. Aangezien tumoren met name in het distale 
deel van de darm worden aangetroffen zal het aanleggen van 
een naad veelal plaatsvinden in het colon en het rectum. 
Ondanks sterk verbeterde chirurgische technieken en 
materialen gaat dikke-darmchirurgie nog steeds gepaard met 
een relatief hoog aantal complicaties als gevolg van het 
optreden van naadlekkage. Naadlekkage in het colon en het 
rectum, waar hoge concentraties van micro-organismen worden 
aangetroffen, kan leiden tot lokale of, in een ernstig 
geval, tot gegeneraliseerde bacterièle infecties. De 
bestrijding van deze complicaties heeft nog (te) vaak een 
fatale afloop, of gaat op zijn minst gepaard met een 
langdurige ziekenhuisopname. Opvallend is dat bij operaties 
aan de dunne darm naadlekkage een relatief zeldzaam fenomeen 
is. 
Het terugdringen van naadlekkages vereist een gedegen 
begrip van de biologische processen die ten grondslag liggen 
aan wondgenezing in de darm. Een belangrijk onderdeel in het 
proces dat leidt tot weefselherstel is de synthese van het 
eiwit collageen. Collagenen zijn uiterst belangrijke 
eiwitten wanneer het gaat om de structurele integriteit van 
een orgaan en worden dan ook massaal aangetroffen in o.a. 
botten, pezen, huid en ligamenten. De sterkte van de 
darmwand wordt eveneens bepaald door collagenen die men 
voornamelijk aantreft in de bindweefsellaag tussen het 
darmepitheel en de spierlagen, de zogenaamde submucosa. 
Onderzoek heeft aangetoond dat het collageengehalte in de 
submucosa ter plekke van de darmnaad postoperatief tijdelijk 
afneemt. Deze afname wordt toegeschreven aan de activiteit 
van speciale enzymen belast met het verwijderen van 
beschadigd weefsel tijdens de eerste fase van het 
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wondgenezingsproces. Gedurende deze vroege fase wordt de 
sterkte van een darmnaad voornamelijk bepaald door de 
sterkte van het weefsel (i.e. collageen) waarin de 
hechtingen zijn verankerd. De hieropvolgende fase wordt 
gekarakteriseerd door een verhoogde synthese van nieuw 
collageen dat geleidelijk de functies van de hechtingen zal 
gaan overnemen. 
Indien het genezingsproces echter niet verloopt zoals 
hierboven geschetst maar bijvoorbeeld de proteolytische 
afbraak door nog onverklaarde oorzaak aanhoudt, zal de wond 
nauwelijks aan sterkte winnen en het risiko op lekkage sterk 
toenemen. Het veruit belangrijkste proteolytische enzym 
belast met de afbraak van collageen is vertebraat 
collagenase (ook wel MMP-1: Matrix Metalloproteinase-1 
genoemd). Dit enzym heeft de unieke eigenschap om een 
eerste, maar voor de verdere collageenafbraak noodzakelijke, 
klieving aan te brengen in de drie eiwitketens die samen de 
collageen helix vormen. De klieving van collagenase heeft 
tot gevolg dat de brokstukken van de helix zich kunnen 
ontwinden waardoor andere proteolytische enzymen toegang 
krijgen tot de eiwitketens en volledige afbraak kan 
plaatsvinden. 
Aangezien er duidelijke klinische verschillen bestaan 
tussen de genezing van naden in de dunne en dikke darm zal 
het simultaan bestuderen van het genezingsproces in beide 
darmsegmenten mechanistische verschillen kunnen aantonen. 
Dergelijk onderzoek levert mogelijk aanknopingspunten op 
voor therapieën ter voorkoming van naadlekkage in de dikke 
darm. 
Het onderzoek zoals beschreven in dit proefschrift heeft 
de enzymatische afbraak van collagenen in en rondom naden 
in dunne en dikke darm van de rat als onderwerp. Het gebruik 
van een diermodel brengt altijd het risiko met zich mee dat 
de observaties niet direkt te vertalen zijn naar de mens. 
Daarom werd eveneens een poging gedaan om humaan en rat 
collagenase (geproduceerd door huid fibroblasten) te 
vergelijken. 
Tenslotte werd onderzoek verricht naar de activiteit van 
het enzym collagenase in humane darmtumoren. 
In hoofdstuk 1 wordt een overzicht gegeven van de recente 
literatuur met betrekking tot de wondgenezing in het 
142 
algemeen en meer specifiek met betrekking tot de genezing 
van darmnaden. De biologisch nauw met elkaar in verband 
staande processen die plaatsvinden tijdens wondgenezing en 
de groei en uitzaaing van darmtumoren worden eveneens kort 
belicht. Het leeuwendeel van dit hoofdstuk behandelt 
vervolgens het eiwit collageen. Een gedegen inzicht in de 
synthese, moleculaire opbouw en de intra- en extracellulaire 
afbraak van dit eiwit is van fundamenteel belang voor 
onderzoek naar wondgenezing en de metastasering van tumoren. 
Hoofdstuk 1 bespreekt vervolgens de enzymen die 
verantwoordelijk zijn voor de afbraak van collageen, de 
zogenaamde metalloproteinasen. Een literatuuroverzicht dat 
de biosynthese, secretie, activatie en regulatie van de 
metalloproteinasen behandelt, besluit de inleiding. 
Hoofdstuk 2 beschrijft de ontwikkeling van een aantal 
laboratoriumtechnieken die nodig waren om het project op 
gang te brengen. Aandacht wordt besteed aan de extractie van 
de collagenolytische activiteit uit pre- en post-operatieve 
rattedarm-segmenten, alsmede de bepaling van 
referentiewaarden zoals totaal eiwit en DNA gehalte. De 
enzymactiviteit werd bepaald in extracten van darmnaden die 
gelijktijding waren geconstrueerd in zowel het ileum als het 
colon van de rat. De collagenolytische activiteit was 12 uur 
na de operatie significant hoger (tot zelfs 4x de controle 
waarden in het colon) in zowel ileum als colon. Gedurende 
de periode van vier weken na aanleg van de anastomoses nam 
de verhoogde activiteit geleidelijk weer af tot een normale 
waarde. Het herstel in het colon verliep veelal trager dan 
in het ileum. Aangetoond werd dat de tijdelijke afname in 
collageengehalte direct na operatie parallel loopt met een 
tijdelijke verhoging in collagenolytische activiteit. 
In hoofdstuk 3 wordt de gevonden postoperatieve verhoging 
in collagenolytische activiteit, zoals gemeten één dag na 
operatie nader gespecificeerd. Deze toename was significant 
hoger in de dikke darm dan in de dunne darm. Het gebruik van 
fibrillaire substraten van collagen type I en III en 
specifieke enzymremmers maakten het mogelijk om een 
uitspraak te doen over de bijdrage van het enzym vertebraat 
collagenase (MMP-1). De aanwezigheid van ММР-1-specifieke 
collageen type I splitsings- producten was het ultieme 
bewijs voor de aanwezigheid van dit enzym. De aanwezigheid 
143 
van andere enzymsystemen was eveneens evident. De gemeten 
verschillen in de afbraak van type I en type III collageen 
impliceren een ondergeschikte rol voor collagenasen 
afkomstig van ontstekingscellen. Dit wijst erop dat een 
geïmmobiliseerde, inactieve, voorraad van collagenasen en 
aanverwante enzymen continue aanwezig is in de 
extracellulaire ruimte. Deze voorraad zou op snelle wijze 
geactiveerd kunnen worden en indien nodig kunnen worden 
aangevuld met nieuw gesynthetiseerde enzymen afkomstig van 
lokale cellen zoals fibroblasten en gladde spiercellen. 
Ontstekingscellen zijn mogelijk betrokken bij de activatie 
van extracellulaire enzym-precursors. De infiltrerende 
cellen zijn daarnaast belangrijk als bron van chemotactische 
en proliferatie-stimulerende signalen. 
De resultaten van bovengenoemde wondgenezingsstudies in 
de rat zouden veel aan waarde kunnen winnen indien 
aangetoond kon worden dat het ratte-enzym enigzins 
vergelijkbaar is met het menselijk enzym. De beschikking 
over gezuiverde enzympreparaten uit rat en mens zou ons 
tevens de mogelijkheid bieden om, tegen deze enzymen 
gerichte, antilichamen op te wekken. Deze antistoffen zouden 
vervolgens gebruikt kunnen worden in immuunlocalisatie en 
enzym-remmings studies. Het volledig ontbreken van 
commerciële enzympreparaten noodzaakte ons de isolatie zelf 
ter hand te nemen. In hoofdstuk 4 wordt beschreven hoe 
fibroblasten uit huid van de rat en de mens in kweek werden 
gebracht en gestimuleerd werden tot secretie van 
collagenase. Kweekmedium, met en zonder serum-
supplementatie, werd verzameld en vervolgens gedeeltelijk 
gezuiverd over een zink-Sepharose matrix gebruikmakend van 
een uitgetest protocol. Tijdens de opzuivering bleek dat rat 
en humaan fibroblast collagenase een afwijkende affiniteit 
hadden voor de scheidings-matrix. De gebruikte methode bleek 
eveneens geschikt om actief collagenase te scheiden van 
latent collagenase. De aanwezigheid van geactiveerd 
collagenase bleek nauw samen te hangen met de aanwezigheid 
van serum in het kweekmedium. Het gezuiverde ratte en humane 
collagenase bleek echter niet te verschillen in de 
capaciteit om intact collageen type I af te breken. We 
kunnen dan ook concluderen dat ondanks de waargenomen 
verschillen in de moleculaire structuur tussen rat en 
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menselijk collagenase de functie van beide enzymen tijdens 
wondgenezing niet dramatisch zal verschillen. 
Onderzoek heeft uitgewezen dat een aantal biologische 
processen die belangrijk zijn voor het vlotte verloop van 
wondgenezing eveneens plaatsvinden tijdens 
tumorontwikkeling. Proteolytische enzymen bepalen in 
belangrijke mate het verloop van vele fysiologische en 
pathologische processen. Het verschil tussenbeide fenomenen 
ligt met name op het terrein van de controle. Het verlies 
van, of het totaal ontbreken van, controlerende factoren kan 
een normaal proces ernstig ontregelen en uiteindelijk leiden 
tot een pathologische conditie. In het afsluitende hoofdstuk 
5 wordt ingegaan op de mogelijke rol van het enzym 
collagenase in de verspreiding en lokale expansie van 
tumorcellen. Het onderzoek werd toegespitst op de capaciteit 
van tumoren om interstitieel collagen type I en III af te 
breken, een proces dat lokale weefselinvasie zou 
vergemakkelijken. Verschillende studies hadden reeds 
aangetoond dat aan collagenase verwante enzymen, de 
gelatinases A en B, een belangrijke rol spelen in de 
verspreiding van tumorcellen via de circulatie. 
De collagenolytische activiteit werd bepaald in extracten 
van 55 humane darmtumorbiopten. De activiteit werd 
vergeleken met de activiteit in de darmwand op enige afstand 
van het tumorweefsel (meestal het resectievlak). De 
resulaten van de enzymstudies werden afgezet tegen o.a. de 
pathologische klassificering van de tumor (volgens Dukes') 
en de mate van differentiatie van het tumorweefsel. Een 
significante correlatie tussen mate van differentiatie en 
enzymactiviteit werd gemeten met hogere collagenase-
activiteiten in tumoren die een lage graad van 
differentiatie ten toon spreidden. Patienten met een tumor 
die reeds de buitenste lagen van de darmwand had bereikt, 
bevatten over het algemeen meer enzymactiviteit in het 
tumorextract dan patiënten met een betere prognose. Deze 
resultaten ondersteunen de hypothese dat proteolytische 
enzymen, en met name enzymen betrokken bij de afbraak van 
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